A child receiving measles vaccine in northern Nigeria. Photo: UNICEF
Poised to completely protect every child against measles infection, the Federal Government has launched a second dose of measles vaccination at 15 months in ensuring that every child is double saved from the disease.
Announcing the commencement of the second dose of measles vaccination on Tuesday, the Executive Director/CEO National Primary Health Care Development Agency, NPHCDA, Dr Faisal Shuaib, said the second dose at 15 months is an addition to the usual first dose of Measles vaccine at nine months.
Shuaib, who spoke through a press statement obtained by Pharmanewsonline stressed the essence of the second dose of the vaccine, in the 19 northern states and the FCT, saying it is to safeguard children from the attack of the disease.
“Dear Nigerians, from the 7th of December 2020, the Federal Government will be introducing measles second dose at 15 months into the routine immunization schedule in 19 states and the FCT.
“The second dose of measles vaccination is given to every child at 15 months as a second opportunity to fully protect children against the deadly measles disease”, he stated.
The World Health Organisation, WHO, recent report shows that Nigeria is among the 45 countries that account for 94 per cent of the deaths due to measles worldwide. Although dearth of data has fraught the availability of population based prevalence, but some studies from tertiary hospitals showed the proportion of measles from pediatric admissions stands at between 1.3-5.1 per cent.
Previous studies have also established that measles is an endemic disease in Nigeria, with recurrent outbreaks occurring at irregular intervals. Measles transmission in Nigeria occurs through all months of the year, but peaks in the dry season. It transmission also sometimes occurs immediately after the end of the rainy season and often reaches epidemic proportions in the dry season. Nigeria is one of only ten countries in the world with measles vaccine coverage of less than 50 per cent.
Encouraging parents to make their children available for vaccination, the NPHCDA CEO assured them that best quality vaccine will be administered on their wards without any adulteration.
“Apart from the usual first dose of measles at nine (9) months old, all children will be vaccinated at 15 months with a SECOND DOSE of measles vaccine.
“I want to assure you that vaccines given to our children are potent, safe and effective. At the NPHCDA, we will continue to do our best to ensure our children are protected from vaccine – preventable diseases. We call on parents and caregivers to always do the needful.
“As parents, we must forsake all doubts and visit the nearest health facility or vaccination post to ensure our children are vaccinated. I have vaccinated my children and urge you to do the same”, he emphasized.
Data presented by an International non-governmental organisation, TechnoServe, has shown that one out of three Nigerian children lack access to folic acid, vitamin A, and iron because of these, their bodies and brains are deprived of key nutrients.
It said, however Nigeria has recently made significant progress in fortifying its staple foods with micronutrients that are essential to achieving better health and nutrition.
“Vitamin A is one of the most critical nutrients kids need to grow up healthy—but too few kids receive a sufficient amount in their diet,” said Bill Gates, co-chair of the Bill & Melinda Gates Foundation.
Vitamin A
He said the world needs to fortify more foods with Vitamin A.
“The leaders in this meeting have already shown what’s possible for wheat flour, salt, and sugar. I hope that by the next time we meet, cooking oil will be added to the list, he said.
Worldwide, more than two billion people suffer from micronutrient malnutrition—deficiencies in essential vitamins and minerals that are integral to healthy growth and development.
The data presented at the 3rd Annual Nigeria Food Processing and Leadership Forum shows that access headed for vitamin A fortified sugar moved from 31 per cent of Nigerians to 96 per cent between 2017 and 2020.
The group said this means about 125 million Nigerians now have access to sugar fortified with vitamin A.
It also said an additional 73.5 million people now have access to wheat flour fortified with iron and folic acid, while 13.8 million have access to cooking oil fortified with vitamin A.
The data shows that to put the scale of these achievements in perspective, an additional 125.7 million Nigerians now have access to sugar fortified with vitamin A; an additional 73.5 million have access to wheat flour fortified with iron and folic acid; and an additional 13.8 million have access to cooking oil fortified with vitamin A.
The group said the progress was achieved following three years of leadership engagement by the federal government and CEOs of the nation’s largest food processing companies.
Fortifying staple foods—such as oil, flour, salt and sugar—with vitamins and minerals has been proven to be one of the most cost-effective and scalable tools to combat malnutrition and save lives.
One out of three Nigerian children under five years are stunted—their bodies and brains deprived of the key nutrients they need to fully develop to reach their full potential.
Over the long-term, stunting results in a 10 to 17 per cent loss of wages. When multiplied across the nation, it’s estimated that Nigeria loses more than US$1.5 billion in GDP annually as a result of diminished productivity and increased healthcare costs.
“If Nigeria is really serious about creating jobs, expanding its markets and growing its economy, nutrition and food systems should be put in the centre of the conversation,” Larry Umunna, West Africa Regional Director, TechnoServe said.
In his remarks, Chairman of the Aliko Group, Aliko Dangote, said the private sector remains the engine of growth for the Nigerian economy.
He said creating a set of compliance standards enhances the chances of delivering foods that will help people live healthier.
An NGO, Marie Stopes International Nigeria (MSION), has urged Federal Government to scale-up Family Planning (FP) policies and services to reduce maternal mortality rate.
The Country Director of MSION, Mr Effiom Nyong-Effiom, gave the advice in an interview with the News Agency of Nigeria (NAN) on Thursday in Abuja.
Nyong-Effiom said improving access to family planning services would reduce incidences of unsafe abortion and enable families to space and plan for the children they could cater for.
He said that the organisation’s target was that by 2030, every woman should have access to family planning services and there wouldn’t be any record of death from unsafe abortion.
“Our target in Marie Stopes International Nigeria is that by the year 2030, no woman should have a need for family planning and not access it, and no woman should die from unsafe abortion.
“This is our 2030 dream, and that means we need to begin to meet people where they have the need even in hard-to-reach areas. No woman should be left behind.
“Government needs to think around that if we really want to eliminate or reduce maternal deaths, which is 507 for every 100,000 live births.”
According to him, MSION, in collaboration with other organisations, trained 7,500 government providers and currently supporting 2,500 Primary Healthcare Centres (PHCs) to deliver voluntary and quality family planning services across the country
Nyong-Effiom explained that the group had developed a franchise model to support 400 private business operators to also give quality family services and post-abortion care services for people who patronise the private sector.
The country director said 23 functional outreach services largely supported by DFID, was also established to enable women to access family planning services easily.
“Each of the 23 outreach services reach about 1,500 women monthly, and it is exciting for us because some of these places have no form of healthcare and we know that is where reproductive needs are highest.
“In 2019, we reached out to 2.4 million women with quality family planning services; this has averted close to 36,000 maternal deaths.
“We all know that FP is one of the cheapest way to reduce maternal deaths,’’ he said.
In response to the COVID-19 pandemic, Nyong-Effiom said the organisation had set up an internal response team to ensure that access to family planning services was not disrupted by the lockdown that followed the outbreak of the virus.
He explained that “within the first three months of the COVID-19 outbreak, we saw 774,000 women in our outreach services, which is more than 38 per cent more than we normally see.
“For our clinics, we started offering more services, for instance if you call our contact centre that you want service but that you cannot come, we will send a vehicle to you or send a service provider to attend to you,’’ he said.
The country director, therefore, stressed the need for stakeholders to carry out more family planning enlightenment events in schools and among youths.
He also emphasised scaling up of services and adoption of family planning methods to reduce maternal mortality and unsafe abortion. (NAN)
Experts have sensitised youths on ways to avoid rape and other forms of violence gainst women and children, the News Agency of Nigeria (NAN) reports.
The seminar for teenagers was organised in Abuja by an NGO, Supporting Hands Initiative (SHI) and WAVE Foundation as part of 16 days activism to end Gender Based Violence (GBV).
The Founder, SHI, Mrs Bassey Ita-Ikpang said the advocacy would educate young pupils on human rights, good attitudes with a view to eliminate all forms of violence and improve hygiene.
Ita-Ikpang decried the increasing cases of violence against women and girls, adding that boys were also victims of such abuse, hence parents and the society needed to also pay attention to them.
“These boys grow and become the future men, so we need to begin talking to them now, inculcating in them from early age on how they should relate with girls.
“We are marking the 16 days of activism to see what we can do differently so we brought in both boys and girls to talk to them, catch them young and for them to grow with the idea that these things are wrong,’’ she said.
She also advised parents to listen, pay attention and monitor their children to enable them detect early any form of abuse or violence they might be experiencing.
On her part, President, WAVE Foundation, Mrs Lola Ibrahim, stressed the need to stop all forms of harmful practices such as Female Genital Mutilation (FGM) on girls.
Ibrahim, who is also a survivor of FGM, decried the physical, psychological and emotional trauma the practice had on the victims.
“Female genital mutilation should be stopped. Girls should be allowed to live a life free from torture, degrading human acts.
“Parents instead of cutting the girl’s genitalia all in the name of you want to keep her intact or away from sex, should educate the child on morals and virtue.
“Let her know the difference between bad and good. Once you educate her, you have empowered her to be able to decide what is right and wrong,’’ she said.
Also, the President Nigeria Association of Women Journalists (NAWOJ), Mrs Ladi Bala, said the seminar would further raise awareness on GBV especially among young girls and boys.
Bala noted that physical, mental, verbal, psychological, economic or emotionally violence leaves a mark on the affected persons.
She, therefore, advised teenagers to report any form of violence with a view to eliminating the practice and ensuring offenders were prosecuted.
An Obstetric and Gynaecology doctor, Amina Ismail-Are, advised teenagers to ensure cleanliness and proper menstrual hygiene to reduce risk of contacting any infection.
Also, Dr Abiola Abiodun, a family Health Physician also sensitised the students on physical hygiene, types of sanitary pad and proper care of the body.
NAN reports that the organisation disbursed menstrual hygiene kits, face masks, writing materials and other items to the students. (NAN)
The latest figures released by the Nigeria Centre for Disease Control shows that the country recorded 318 new COVID-19 infections, with no related fatalities in the last 24 hours.
The NCDC disclosed this on its verified website on Sunday.
The public health agency stated that 124 people were discharged after recovery from the disease from across the country during the period under review, saying “our discharges today include 60 community recoveries in Lagos State.”
It added that the new infections took the country’s tally of COVID-19 cases to 69,255, noting that about 803,621 tests were conducted since the first confirmed case relating to the COVID-19 pandemic was announced on Feb. 27.
The health agency stated that Lagos recorded the highest number of the new infections with 104, while Kaduna, FCT, Rivers and Ogun confirmed 59, 50, 17 and 16 new infections respectively.
The centre said that a multi-sectoral national Emergency Operations Centre, activated at Level 3 has continued to coordinate the national response activities.
The NCDC noted that till date, 69,255 cases have been confirmed, 64,774 patients discharged and 1,180 deaths recorded in 36 states of the federation and the Federal Capital Territory.
Meanwhile, the agency advised Nigerians to continue to abide by the COVID-19 protocols by frequently washing their hands under running water, observing social distance and wear a face mask. (NAN)
At 71, Pharm. (Dr) John Nwaiwu sits at the helm of affairs of Lagos-based JB Pharmaceuticals Limited, a fast-growing pharmaceutical company he founded after a very successful career at the Nigerian Customs Service, where he retired as an assistant comptroller-general of customs. In this exclusive interview, Nwaiwu, who was also a former pharmacy lecturer at the University of Nigeria, Nsukka (UNN), recounts his early years, his professional exploits in public and private spheres, and his views about the COVID-19 pandemic. Excerpts:
Pharm. (Dr) John Nwaiwu
It is our pleasure to feature you in this edition of our “Senior Citizen of the Month” interview series. Kindly tell us about your background and early life?
I am from Onichi in Ikeduru Local Government Area of Imo State. I started my elementary school at Christ the King School, Aba, Abia State. So I am an Aba man. From there, I went to Trinity High School, Oguta, for my secondary education. I did my A levels at St Patrick’s College, Calabar – although the war disrupted our studies. I travelled abroad after the war because the conditions in the then Biafra were not conducive enough for anyone to study, as the universities had been destroyed. So I left the country and went to the Philippines where I studied at the University of Philippines and obtained my first degree in Pharmacy.
After this, I proceeded to London, and soon obtained my doctorate degree in Pharmacognosy at the University of London. On coming back, I was employed at the University of Nigeria (UNN), Nsukka, in the Faculty of Pharmaceutical Sciences. I rose from the position of lecturer 2 to senior lecturer. From there, I found myself at the Nigerian Customs Service.
What factors or personalities would you say helped to shape your values and principles in life?
In our early days, around the early 1960s, our parents were strict disciplinarians. They were so strict. Aba in those days used to be a closed society and parents used to compete among themselves trying to see whose child was doing better and all that. This helped to influence us as children those days and educational competition was healthy. There was no rancour at all. That made all of us come close together and we knew ourselves. We shared a lot together and each person influenced the other. There was competition in the areas of mathematics, sciences and in fact, football. The peer group had a great influence on us.
How did you come about the choice of Pharmacy as a profession and how has this choice affected your personality? Did you have role models who influenced your choice?
As I said before, Aba was a closed society in those days and there was healthy academic rivalry among young chaps. There was one Rufus Obi Pharmacy in Aba in those days. He was the only pharmacist around, apart from Klinkland Chemist in Aba, and we admired him a lot. This shaped our thinking towards Medicine and healthcare delivery.
If you were playing football for example and sustained injury, the person would be taken to the local pharmacy shop or medicine shop to be attended to. They were the doctors we knew those days. So those things made us to aspire towards healthcare delivery. This motivated some of us to study Pharmacy, some Medicine, and some other medical sciences. We still relate even till today.
You had a very successful career at the Nigerian Customs Service. At what point did you veer from mainstream pharmacy practice and did your training as a pharmacist contribute to this enviable career in the customs service?
I was a senior lecturer at the Faculty of Pharmaceutical Sciences, University of Nigeria, Nsukka (UNN). Then, I used to move around and one day, I ran into a group of people and they were messing with this idea of drugs. At that time, the Nigerian Customs Service was in charge of drug interdiction. I fell into an argument with them about what hard drugs were. They didn’t know which one was which. I did Pharmacognosy and I was really pained that some people were just mixing up things.
To cut the long story short, somebody came and challenged me to join the Customs Service if I felt I knew better about drugs. I resisted the idea because, to me, joining the Customs Service was not part of my plans; but my in-law persisted that I should give it a trial. So, I took transfer of service to the Nigerian Customs Service on experimental basis. I came to the Ikeja training school after which I was sent to Defence College, Jaji, on leadership training.
At Jaji, the issue of discipline came up again. I didn’t know that the army was a highly disciplined unit, such that if you were just walking across the road close to the parade ground, you must march or get punished. That inculcated some extra discipline in us and it was very good. After my training, I came to join my colleagues in the customs service and because of my training as a pharmacist, I was in the department of drug interdiction.
Being in the department of drug interdiction at that time at the Nigerian Custom Service, took us to almost all parts of the world, discussing drug interdiction and the knowledge of drugs. At one of the conferences for heads of national drug agencies in Vienna, Austria, when the issue of Nigeria came up, Americans were disturbed and wanted to give some help to Nigeria in the fight against illicit drugs but they had issues with the Nigerian government’s agency to liaise with. They didn’t know whether to relate with the Ministry of Health or the Customs Service and so on. I was there representing Customs Service.
When I came back to Nigeria, the then head of state decided that Nigeria should have a drug enforcement agency. Eventually, the then Attorney General of the Federation was asked to put it down in a legal framework. He now drafted it as the National Drug Law Enforcement Agency (NDLEA) and it was created under the Ministry of Justice. That was how NDLEA ended up in the Ministry of Justice. The Nigerian Police was there asking for it, the Nigerian Customs Service was there asking for it, the Ministry of Health was also asking for it. But the Attorney General was a legal man and was very influential those days.
That was how the NDLEA was created under the Ministry of Justice. It was justified and they have been doing very well since that time because whatever offence you commit, you still have to go through the law. However, when the agency was moved to the Ministry of Justice, I found out that my potentials and training as a pharmacist were no more fully utilised, so I got engaged in other areas.
What guided me while I was there is that discipline that the pharmacy profession inculcates in you. Every pharmacist is a disciplined person; and I need to make this point, if you are not disciplined, you cannot be a pharmacist. For example, if they ask you to add 30 grams of a particular molecule in drug formulation, if you add 35 grams, somebody is dead. If takes a lot of discipline to be a pharmacist and it is very important. Pharmacists are supposed to be highly disciplined people.
Not many pharmacists who rose to such an outstanding height in public service are able to also achieve giant strides in core pharmacy business like you have done. How were you able to manage these two rungs of the ladder?
When I retired from Nigerian Customs Service, I told myself that I couldn’t do any other thing apart from Pharmacy. That is my profession. A lot of people wanted me to go into politics. So I stayed focused on what I wanted to do and stayed away from politics. So, when I started pharmaceutical business, I brought that same discipline to bear on our operations. That is responsible for the modest achievements we have recorded so far in our business
With your experience at JB Pharmaceuticals Limited, what would you say are the core issues affecting the pharmaceutical industry in Nigeria and how can these issues be sorted out?
Thank you for this question. Pharmacy practice, whether you are into manufacturing, importation or wholesale, has something to do with importation. If you are manufacturing, you will have to import the machineries, the raw materials and so on. If you are into wholesale, you still have to import the finished products and when the exchange rate continues to dance like a yoyo, you are finished as a businessman.
That is the problem we have in Pharmacy today. Here, the exchange rate is constantly changing, without reasons. It is difficult to practise effectively as a result of these fluctuations. It’s difficult to make business decisions and projections. So, irrespective of whether you are importing or manufacturing, the exchange rate is a very important thing. The inconsistency in government fiscal policy is a problem. Today, they tell you this product has a 10 per cent waiver, tomorrow they tell you it’s now 20 per cent and so on.
An entrepreneur must have, at least, a five-year development plan and when government policy is not steady, it’s difficult to make business decisions and plans. Some people believe that this era of COVID-19 is really favouring the pharmaceutical industry, but it’s not true. This is because seaports are closed at this time. Although, the curfew is relaxed now and people are being allowed to move around, the seaports are closed. Meanwhile people’s goods are there accumulating demurrage. There are lot of inconsistencies in such things as import adjustment tax, import duty and other import related policies.
Again, we must speak with one voice in our profession, whether you are an importer, manufacturer, academic pharmacist, community pharmacist and so on. All of us must be together, if we must forge ahead. Once we begin to have disparity and misunderstanding, problems will come in.
We are able to achieve the much we are achieving now because we have a united front and we speak to government with one voice.
Kindly tell us about some of your positions of service to the pharmacy profession and which of these do you consider most challenging?
You got me there (laughs). Let me go through. I was chairman, Board of Fellows of PSN. Currently I am chairman of the Pharmacy Tower Committee, responsible for the mobilisation of funds for the construction of the PSN Pharmacy Tower.
I was chairman of Lagos Property Committee. I was also chairman of the Election Committee. That was the committee that organised the election of the last PSN government. I was also chairman of the Privileges Committee. That is the committee that elects members of the PSN Board of Fellows. I was also a member of the disciplinary committee. I was at some point chairman of the Research Grant Committee and the Endowment Committee.
Out of all these, the most challenging one is being chairman of the Pharmacy Tower Committee. I was asked to build a house that will cost N1.89 billion and you know we don’t have money. So it’s most challenging trying to mobilise people to bring money. Unfortunately for us, it now came also up during the period of COVID-19. Some of those who had promised to give us money are now struggling through the challenges or burden that COVID-19 has placed on businesses worldwide. But we are not relenting. My team and I are poised to deliver on that assignment. The assignment is causing me sleepless nights.
I am always thinking of who to meet for funds. But luckily for us, we have been getting positive responses. Luckily also, the PSN president is a very God-fearing and prayerful person and he will never let you go unless you deliver. He also encourages you and gives you advice at every point in time. Above all, he is also a very experienced man. Unless that structure comes up to an appreciable level in at least the next two years, I will not have rest of mind.
We are also very grateful to Pharmanews for helping us to publicise this information. Some people have read it up from Pharmanews and have called us to request for the form. We thank Pharmanews for that.
What are your thoughts about COVID-19 and the various efforts aimed at finding a solution to the pandemic? How can government encourage research institutions and pharmaceutical companies towards finding a locally-driven cure?
The emergence of COVID-19 confused the whole world. It’s only about three or four months ago that people started having an idea of what the pandemic is all about. These days, more awareness and information have come out about COVID-19. Even though I studied Pharmacognosy and I know what drug information is all about, I am one of those people who will ask you questions about active ingredients if you claim a plant does this or that cure. If you don’t tell me the active ingredient, it means you are guessing. If it is not an active ingredient, it means it is a crude extract.
Crude is crude. Although some crude extracts are very active but you can’t pinpoint what exactly is responsible for what. Is it water or is it the alcohol that is used in extracting it? So you will need to do more analysis to know this. You also will need to carry out toxicity tests. Some of us actually doubt the use of medicines to cure COVID-19. People are laying claims to various discoveries of cure for COVID-19 but I have a feeling that COVID-19 is a viral disease and being a viral disease, it requires the antibodies to cure the disease and eventually that is what is going on now.
People are looking for vaccines. Anybody claiming to have a cure is merely curing the symptoms. The virologists will tell us that a virus is not something that you kill or kill its cell. Where do you see it in the first place? For me COVID-19 is real and if the vaccines come out, it will phase out like other viral diseases. It requires an anti-body to take care of it.
Government should encourage the production of vaccines. Government needs to support the pharmaceutical industry and fund researches. Research is not cheap. I can attest to this fact as a former university lecturer
Finally, what advice would you give to the younger generation of pharmacists on how to make the best use of their calling as healthcare professionals to impact humanity positively?
They should be disciplined. If you have self-discipline, you will not venture into what you cannot afford because that is what brings about greed. Young pharmacists should be patient and work diligently towards attaining their goals and aspirations which must add value to society and humanity in general.
The COVID-19 crisis is creating an extraordinary strain on society. This is caused by the infection in itself, as well as the fear of infection, and the physical, emotional, and financial implications of physical distancing. In Nigeria, healthcare professionals (HCPs) are facing unprecedented challenges and the health system in general faces unprecedented financial issues.
Pharm. Tunde Oyeniran
Across medical specialties and therapeutic areas, the treatment of patients has fundamentally changed. HCPs are rapidly adjusting how they deliver care (such as through increased use of telemedicine). As a result, the support they need from pharma companies, payers, and other stakeholders is also changing. The realistic view is that the effects of COVID-19 are not disappearing soon
Beyond that, however, pharma corporate leaders and industry leaders have to deal with the fact that the COVID-19 crisis will have knock-on effects for the broader pharma environment. This will happen in the following ways:
The underlying economic crisis triggered by the COVID-19 pandemic will have a significant ripple effect on state and national budgets. Urgent and costly measures to shore up businesses and support individuals will force governments to contain outlays in every category, including healthcare.
The incremental innovation required for premium-priced drugs will continue to rise, as will pricing pressure on commodity products such as generics and biosimilars. Unfortunately, patients cannot absorb all of the increase in cost, thus squeezing profit, especially for the generic-drug marketers.
Pharma companies will delay some product launches, and those that go ahead may fall short of expectations. Leadership teams may face disrupted supply chains, delayed clinical trials and lack of access to physicians and other medical forums.
More significantly, pharma executives will need to adjust go-to-market strategies for previously planned product launches.
The COVID-19 crisis has been a massive shock to the healthcare system in each of these areas — utilisation, adoption of new behaviours, and pharma engagement. A range of changes can be seen across specialties and geography. This variation is critical for pharma leaders in crafting effective strategies for crisis recovery.
For marketing and demand-generation teams, our initial observations and conclusions are:
Fewer patients seeing physicians and fewer prescriptions for most disease areas. Sales will struggle as a consequence of this.
Rising use of telemedicine, online CMEs and other remote tools does not offset the loss of in-person interactions. It only compliments it and improves reach.
The decline in pharma-healthcare professionals interaction is significant and will not return to normal levels anytime soon.
There is a need to revamp how to engage with healthcare practitioners and patients.
It is absolutely necessary to re-imagine what the commercial mix should be to accommodate new needs and preferences.
The above points are general, but the following are direct, practical recommendations that can be used immediately:
Manage your outstanding. Cash is the blood of any business, far more important than profitability for the short-term survival of the enterprise. It will be important that your sales force brings back money as quickly as possible. Sales managers and CEOs will need to enforce and encourage them to do this by putting up necessary policies, incentives, strategies, etc.
Demand-generation should never cease. Whatever happens, you cannot take a pause from the actions and activities to generate demand. You only need to ensure the field force does the needful in this regard. Ramp up motivation, sanctions, incentives and the necessary supervision to get this going. However this does not mean that you should take risks with the workers’ health, especially with respect to COVID-19
Relationship building and marketing all the way. In times like this, strong relationship built over time with customers and HCPs comes handy to overcome the challenges of selling in a tough economic environment. If your team/company hasn’t built strong relationships yet, now is the time to focus on strengthening relationships and growing your market share. This can be taken a notch higher by institutionalising it and providing direct support for this effort.
Do more with technology and social media. In these days of social-distancing and other COVID-19 preventive protocols, leveraging technology to keep going while keeping safe has become imperative. Perhaps the only positive outcome of the pandemic has been greater acceptance of online interactions, meetings and trainings, with more personal investment in hardware, knowledge base and change of attitude than ever. All of these made it easier to use technology to reach, meet and interact with HCPs, customers and field staff. What is more, it is more flexible and cheaper than face-to-face meeting in most situations. Pharma company must maximize this opportunity by taking as much as possible their meetings, reporting, CMEs, customer interactions, etc. to the cyberspace
Retailers’ influence is growing, and you need to latch on. Community pharmacists erect relatively little or no barrier against medical sales representatives and are therefore more available for them. Concomitantly, patients feel more secure from the risk of COVID-10 infection in pharmacies, and are taking their health challenges to them. I believe this trend will continue and most likely remain permanent. Traditionally, they represent the final leg of the route-to-the-market. They are therefore important to improve access to your drugs and shelf-presence. Pharmaceutical marketing companies need to shepherd their reps in this direction, in addition to developing long term relationship with them
Succeed through follow-up and persistence. Successful companies know that follow-up and persistence win new business. When your clients/prospects are cash-strapped and stressed in their own ways, they may not respond to your calls and emails immediately. Remember, they have other priorities on their mind—don’t take it personally. Prioritise sustaining your connection with clients and prospects, trusting in the eventual gains. The biggest failings of companies are poor follow-up, no follow up, and giving up. As we all know, the work does not end with the sale.
People are assets, but that is only if they are disciplined, well- supervised and productive. In all of this, sales leaders know that people are central to success. So, do your best to take care of your people and be open about challenges and expectations. Take into considerations their challenges in the current environment. But it is important to provide adequate supervision and maintain discipline to keep productivity at the highest level possible.
The Pharmacists Council of Nigeria has pledged to strengthen the fight against HIV/AIDS by enforcing regulatory practices governing drug administration and usage as it concerns managing the virus.
The PCN Director, Inspection and Monitoring, Mrs. Anthonia Aruya, made the pledge in an interview with the News Agency of Nigeria in Abakaliki on Sunday, as a reminder to the occasion of the 2020 World AIDS Day.
The day is annually celebrated on Dec. 1 since 1988 to raise awareness of the AIDS pandemic, caused by the spread of HIV infection and mourn those who died of the condition.
Image of the PCN logo
The theme for 2020 is “Ending the HIV/AIDS Epidemic: Resilience and Impact” aimed at focusing more attention to the HIV scourge, increase awareness and knowledge, as well as speak against stigma.
Aruya said that as a regulatory agency covering facilities and premises, institutions and various aspects of pharmacy practice, PCN was actively involved in steps and actions taken at the level of Federal Ministry of Health, as well as collaborate with donor agencies in managing the HIV/AIDS scourge.
She said that the enforcement of regulatory practices governing drug administration and usage regarding the management of HIV cases in the country was of utmost importance.
She explained that the measure was to streamline drug distribution value chain to promote the availability of safe, effective and quality medicines, including the Antiretroviral drugs and relevant supplements.
She said “we bring our contributions on the issue of drug administration and regulation, as well as enlightenment, among other collaborative efforts, aimed at checking the infection rate and management of the deadly virus.
“The PCN drug regulatory and management activities are in fulfilment of its mandate stated in the PCN Act, Cap P17, LFN 2004.”
Mr. Chike Arisa, a pharmacist based in Abakaliki, urged the federal and state governments to step up collaboration with donor agencies to ensure steady supply and provision of ARV drugs to manage infected persons.
He said, “the COVID-19 has relegated HIV/AIDS to the background, with too much attention given to the former, which has ravaged the world since December 2019.
“It should, however, be observed and propagated with massive enlightenment that while many COVID-19 patients have been cured, people living with HIV can only manage and have to live with it for life, as it has no cure yet and has been killing people.”
He urged relevant authorities to continue to propagate the preventive messages of HIV/AIDS alongside that of COVID-19.
The Civil Society for HIV/AIDS in Nigeria, Sokoto State Chapter, said on Sunday that the fight against the virus was being undermined by poor funding and non-release of allocated funds.
CiSHAN Deputy State Coordinator, Mohammed Garba, disclosed this in an interview with the News Agency of Nigerian in Sokoto.
According to him, funding has remained the greatest challenge affecting HIV programmes in the state, adding that the problem, if not addressed, will reverse the achievements so far recorded.
“For us in Sokoto State, it has not been an easy ride. We all know the issues around HIV funding.
“Since the World Bank project stopped in Sokoto, it has been very challenging and difficult getting funding for HIV intervention programmes.
“The last HIV intervention by the state government was in 2014, which was a World Bank project called HIV/AIDS Fund II. Since then, it has not been very easy.
“Due to poor funding and budget releases, the Sokoto State Agency for the Control of AIDS, Tuberculosis and Leprosy was only able to organise World AIDS Day.
“Over the years, what SOSACAT has been able to do with Civil Society Organisations is, from time to time, come together to organise activities for World AIDS Day.
“But as a major stakeholder, I think that it should go beyond commemorating World AIDS Day.
“There should be activities that should target the population, people like the female sex workers, uniform servicemen, and the youth, who are more vulnerable.
“This can only be possible if the government is willing to release more funds for HIV intervention,” he said.
He said that more attention was being given to COVID-19 at the expense of HIV/AIDS which had continued to spread among the population.
He said that drugs were still being provided by development partners, stressing that by the time the partners pull out, it would be devastating for people living with the virus.
“My call to the government is that once there is approval, the budget and finance ministries should make sure there is a timely release of funds.
“We may be looking at the current 0.4 per cent prevalence of HIV in the state, but if we relax too much, we all know what will happen – the prevalence rate will shoot up,” he warned.
He said that CiSHAN, with more than 50 CSOs membership, would continue to advocate for improved funding for HIV interventions for prevention and impact mitigation of the scourge in the state.
He said that the group had done a lot in the area of awareness creation and holding government to account, while also providing support to people living with HIV and AIDS.
“We are supporting them with cash, sewing machines, grinding machines and other forms of support for self-reliance, including school fees and transport fare to enable them access drugs in hospitals,” he said.
He advised people living with the virus against self-denial, which according to him, fuels stigmatisation.
He said that CiSHAN was working with Network of People Living with HIV and AIDS in Nigeria to sensitise people against stigmatisation.
Garba pointed out that the ugly trend, if not checked, could push people living with the virus to infect others deliberately.
When contacted, Alhaji Umar Alkammawa, Executive Secretary, Sokoto State Agency for the Control of AIDS, Tuberculosis and Leprosy, confirmed the challenge of funding for HIV programmes in the state.
Alkammawa, however, said that the state government was trying it’s best “in view of dwindling resources and competing demands from different sectors”.
The Senate has urged the Federal Government to make sufficient funds available for procurement and administration of COVID-19 vaccines for Nigerians.
It described as unfortunate the failure by government to produce a plan for the purchase, distribution and administration of the therapy despite the fact that many nations globally had done so.
Adopting a motion sponsored on Thursday, Dec 3, by Senator Oloriegbe Ibrahim during plenary presided over by Senate President Ahmad Lawan in Abuja, the upper legislative chamber directed its Committee on Health and Primary Health Care to summon the Ministries of Health and Finance, as well as the Presidential Task Force (PTF) on COVID-19 and other relevant agencies for their plans.
UK Coronavirus Vaccine Prompts Immune Response in Early Test
The lawmakers regretted that “the only plan on COVID-19 vaccine for Nigeria is the pledge by Global Alliance for Vaccine Initiative (GAVI) to support 20 per cent of the country’s requirement.”
This support, according to them, would cover only the cost of the treatment without taking care of logistics for distribution and administration.
The legislature added: “Despite the change in the epidemiology trends of the disease, the financial plan developed by the country and World Bank in April 2020 to fund the response to the pandemic is still being implemented without taking due cognisance of the changes by re-allocating the funds to vaccine procurement.”
It noted that failure to administer vaccines in the nation would result in Nigeria’s inability to contain further infections and a possible ban on Nigerians by countries across the world.
“Who looks outside, dreams; who looks inside, awakes.” – Carl Jung
On 24 January, 2018, Jack Ma, founder, Alibaba Group, that employs 65,000 staff, was hosted as guest during ‘‘Meet the Leader Session’’ at World Economic Forum held at Davos, Switzerland, from 23 to 26 January. I listened as the e-commerce business guru unleashed his thoughts on business from a position of authority. He told the story of how he started from humble beginnings and how he had to prepare himself to compete in future because he didn’t have the resources to compete at that time.
George O. Emetuche
During the thought-provoking interview, Ma admonished that people should look more inside than they look outside. The inside determines a lot about what will happen outside. I believe that once you conquer within, you will conquer your environment.
The truth of the matter
I have not seen any real success story without hurdles, challenges or tough situations. The year 2020 has been an amazing year! It is a year filled with happenings that we hadn’t planned for – from the COVID-19 pandemic, to the lockdown, to the EndSARS protest and the curfews that followed in some states. But in all this, we still have to be happy for the gift of life. We need to celebrate life and thank God for preserving us this year.
Don’t count your losses. This is the time to look inwards and count your lessons. I tell my team that this amazing year is a year of soul searching. This is a time to ‘‘get into yourself’’ and think through from January to December. When you think through, you will see that life is a gift. We need to be alive first before talking about the targets we met or the ones we didn’t.
Staying alive is a big target met
As a training consultant who prepares a lot of salespeople and other professionals, I talk a lot about meeting or exceeding sales target. In fact, I have developed models that help sales professionals to exceed their targets. I motivate professionals to go the extra mile for top performance. We help professionals to build capabilities; this is our job.
However, in looking inside, more than we look outside, you will agree with me that there is a time to attack and a time to retreat. This is a smart military strategy. There’s a time you stay in business to just maintain the status quo. At such a time, your target is to ensure you maintain normal business routines without necessarily thinking about growth or expansion. This year 2020 is one of such times in many businesses and families.
Look around you as you read this piece. I am being very intentional this moment. This is the last month of the year and we are taking personal stock; we are looking inwards. Have you looked around you? Okay, please go close to a mirror. Have you done that? Look at the mirror and see yourself; see how you are glowing! See that you are hale and hearty; see that you are alive and well, even in the midst of all the challenges. If you can see yourself in that mirror, it means you won. It means you have exceeded your target this year!
A time to revisit the drawing board
Our businesses must move on profitably. We must think progressively in the midst of tough situations. It is a good strategy to retreat sometimes in order to attack strongly later. But you can’t do a lot when you don’t evaluate yourself periodically. You need to slow down sometimes to appraise your performance. This is why I recommend that we look inside this period; this is the time to get to the drawing board and think up smart strategies for next year.
Look inwards to ascertain the best ways to achieve your goals next year. What is deposited within you is greater than the challenges in your environment. As a business-owner or professional, how are you planning for year 2021?
I believe that when disruption becomes evident, disruptive innovation becomes inevitable. No amount of challenges can withstand consolidated assaults coming from the mind-power of a focused and determined individual. Wear your thinking cap and get to the drawing board. Look more inside in order to conquer the outside. This is the right time to build the right capabilities in your team by training and retaining them. This is the time to plan. This year presented a lot of challenges which must be surmounted by sustained assaults of competence and know how.
See you in Productive 2021!
God bless.
George O. Emetuche is a Brian Tracy endorsed bestselling author, accredited training consultant, life coach, sales and marketing consultant. Please reach us today for cutting-edge training of your team. Order a set of our seven bestselling books and one audio book @ normal Total Price of N16, 500 only and get free delivery anywhere in Nigeria! Please call, 08186083133, 07060559429 or visit, www.thesellingchampionconsulting.com.
Buy Books by George O. Emetuche from bookshops or malls near you. They are:
1. The Selling Champion. 2. The Art of Selling. 3. The 25 Unbreakable Laws of Sales. 4. The 11 Irrefutable Principles of Success. 5. Everything is Possible. 6. Be Inspired. 7. Succeeding With Your Spouse.
Dr Lolu Ojo is a technocrat, with extensive and meritorious public and private sector experience. Born in Gbongan, Osun State, he had his elementary education at St. Paul’s Primary School, Oyo State. For his secondary education, he attended Ilora Baptist Grammar School and Ibadan Grammar School, respectively.
Dr Lolu Ojo
Thereafter, he proceeded to the prestigious University of Ife (Obafemi Awolowo University) in 1980, where he bagged his Bachelor of Pharmacy (BPharm) in 1984. He spent some time acquiring field experience, before returning to the academic world in 1989 for his Master of Business Administration (MBA) degree at the University of Benin. He subsequently obtained his Doctor of Pharmacy (PharmD) degree from the same institution in 2009.
An industrious Ojo served organisations like Roche Nigeria Limited and Coca-Cola Nigeria Limited as a top management expert, before setting up his own company, Merit Healthcare Limited in 2005.
He has also deployed his vast knowledge and experience to serve the Pharmaceutical Society of Nigeria (PSN) in various capacities. These include being two-term chairman, Conference Planning Committee (2008, 2017); national chairman, Association of Industrial Pharmacists of Nigeria (NAIP); chairman, National Drug Distribution Committee; founder and pioneer managing director of Ultra Logistics Company Limited; chairman, Drug & Substance Abuse Committee; chairman, Pharmacy Education Summit Committee; and chairman, Research, Documentation and Industry Liaison Committee, to mention a few.
Ojo was at the centre of the planning and execution of many epoch-making events and activities for the progress of the pharmacy profession in Nigeria. Accordingly, he has received many awards and recognitions for his contributions to the growth and development of the pharmaceutical industry and the pharmacy profession in Nigeria. He is a recipient of Merit Award from the Lagos, Bendel (now Edo and Delta), Ogun and Ekiti State branches of the PSN. He also won the Distinguished Service and Eminent Person’s award of NAIP and many more.
Ojo is a Fellow of the Pharmaceutical Society of Nigeria (FPSN), Nigeria Academy of Pharmacy (FNAPharm), Distinguished Fellow of the Professional Excellence Foundation of Nigeria (DF-PEFON) and Courier and Logistics Management Institute (FCLMI). He is a member of the Presbytery of the Apostolic Church, Sunday School leader and Chairman of the building committee.
Dr Lolu Ojo is an avid reader and writer and has published many articles in national newspapers and pharmaceutical journals. He is married to Bridget Ojo, who is also a director at Merit Healthcare Limited, and their union is blessed with five children.
Honey is a sweet liquid made by bees, using the nectar from flowers. According to modern scientific view, the best bee’s honey is made by Apis mellifera (Family: Apidae). Honey is called zuma in Hausa, mmanu anu in Igbo and oyin in Yoruba.
Constituents
Honey has a very complex chemical composition that varies according to the botanical source. Honey comes packed with vitamins (such as pyridoxine, riboflavin and niacin), amino acids, trace enzymes, and many important minerals, such as calcium, iron, magnesium, potassium, sodium chlorine, copper, zinc, iodine and phosphate. Due to its pH ranging from 3.2 and 4.5, it is acidic in nature.
Flavonoids and polyphenols, which act as antioxidants, are two main bioactive molecules present in honey. Honey has high levels of monosaccharides, fructose and glucose, and it contains about 70 to 80 percent sugar, which provides its sweetness. It has been valued as a natural sweetener, long before sugar became widely available in the 16th century.
Honey
Preparations
Honey can be added to tea, coffee, milk, breakfast cereal, snacks or various dessert recipes, as a sweetener or topping.
Pharmacological actions and medicinal uses
Honey has a long history as a natural medicine. It is used to treat ailments of the internal organs and the skin. The ingredients of honey have been reported to exert antioxidant, antimicrobial, anti-inflammatory, antiproliferative, anticancer, and antimetastatic effects; thus its potential therapeutic role in the treatment of diseases.
Many evidences, according to modern literature, suggest the use of honey in the control and treatment of wounds, diabetes mellitus, cancer, asthma, and also cardiovascular, neurological, and gastrointestinal diseases, like ulcers, constipation and nausea. It is known for its effectiveness in instantly boosting the performance and endurance of athletes, as well reducing muscle fatigue. Honey releases the sleep-promoting chemicals in the body, thereby relieving insomnia.
Honey’s wound-healing properties are among its most impressive medicinal qualities. Honey heals superficial burns. Honey helps to heal wounds by providing a protective barrier against germs, naturally absorbing fluids in wounds, helping to prevent the growth of bacteria and fungi. The enzyme in raw honey, glucose oxidase, reacts with body fluids to produce hydrogen peroxide, which acts as a mild antiseptic.
Also, the presence of a bacteria-killing agent, called inhibine, helps to keep open wounds sterile and prevents further infections, gangrene and other complications. Some studies have revealed that Manuka honey may even be effective in the treatment of MRSA infections.
Honey acts as a demulcent and soothes the throat, relieving it from pain and irritation and suppressing cough in less time than other cough syrups. As honey is rich in anti-oxidants, it gives proper nutrition to brain cells and keeps it in an optimal state, keeping the memory sharper as one ages.
Honey helps to relieve hangover by speeding up the liver for the faster oxidation of alcohol. The International Journal of Food Sciences and Nutrition, in an edition, stated that honey promotes healthy heart by improving blood circulation and preventing clogging of the arteries.
Adverse effects
Honey may contain botulinum endospores that cause infant botulism in very young children, a rare but serious type of food poisoning that can result in paralysis.
Economic uses and potentials
A Nigerian study indicated that honey production is very profitable with a gross income of ₦890 per litre (US $7) and ₦4888 per man-day (US $ 41) on average. Econometric analysis shows that number of hives, labour and fixed assets have significant impact on honey output. Opportunities abound for unemployed graduates and people in rural areas in beekeeping as a source of livelihood.
By Pharm. Ngozika Okoye (Nigeria Natural Medicine Development Agency)
Year 2020 has been an unprecedented year for a myriad of individuals and organisations. The COVID-19 pandemic has severely affected the socio-economic landscape of the world in general and Nigeria in particular.
However, despite the negative impacts of the pandemic on the wellbeing of people and businesses, we are still provided with the rare opportunity to develop a resilient mindset in order to tackle the big and small challenges we are going to face in our personal and professional lives.
Pharm. Sesan Kareem
By the way, the essence of life itself is to overcome challenges and solve problems. In view of this, below are three strategies you can adopt to develop a resilient mindset:
Develop a positive perspective
Perspective matters. The way you see things shape your state of mind. Your mindset is your habitual way of thinking that influences your emotion, which determines your behaviour. To overcome difficult times, setbacks or life’s challenges, you must strive to see the cup half-full instead of half-empty.
Three factors shape your perspective: meaning, mindset and motivation. The meaning you give to life’s events or experiences determines your state of mind. Are your current challenges the beginning of your business or the end? Is God punishing you or preparing you for greater things in the future? Your answers to the above questions determine your meaning.
Your mindset determines your motivation. Motivation is simply the motive to take action, the reason to belief more in yourself. For clarity purpose, if you see the current challenges you are facing as a learning opportunity to re-strategise, develop your leadership acumen and create a better culture in your life or business, you will develop a positive mindset, which in turn will determine the actions you will take and not take for you to survive this period and thrive moving forward.
Let me ask you these questions: What is your attitude towards your current challenges in your business or career? What meaning do you attach to your current experience? What are your habitual thoughts about what is happening in our world? What reasons will inspire you to keep on keeping on and finding a way to turn your setback to a comeback?
Develop a positive attitude
Attitude is everything. To turn things around in difficult times, you must do things differently in your life and business. To do things differently, you must develop a positive attitude. Attitude can be defined as the way people think and feel that determines their behaviour.
Behaviour is just a reflection of a belief system. How people act is a reflection of how what they think and how they think. To grow, thrive and succeed, despite turbulences, as an individual or organisation, requires new ways of thinking about problems, value creation, customer service, marketing, operations, structures and innovation.
It is also important to work on your emotions to feel good, inspired, motivated, energised and empowered, regardless of the challenges you are facing right now in your finance, career, health, relationship or business. More often than not, when things are tough, people feel bad, frustrated, overwhelmed, disempowered and lost. We all have a choice, and it is a mental choice to be in charge of our emotions, or allow events, circumstances or situations to control our thoughts, feelings and actions.
Develop positive habits
Habits form results. It is a truism that if you can change your habits, you can transform your results. Human beings are habitual in nature. We are what we do on a daily basis. Habits are daily routine you consciously or unconsciously engage in.
We all have habits; these habits determine the quality of our health, relationship, happiness, career and finances. It is easy to form negative habits in thinking, feeling and behaviour. However, it is difficult to stop negative habits, especially when they have become a second nature.
On the flip side, it is quite difficult to form positive habits of thoughts, emotions and character because it requires discipline to keep them. Below are some habits you must develop in order to experience peace, joy, love and abundance, regardless of what life throws at you.
* Meditation: It calms your body, mind and soul, so that you can perform life functions optimally.
* Visualisation: It helps you to have a clear vision of who you want to be, what you want to do and have.
* Affirmation: it strengthens your belief systems.
Gratitude: It focuses your attention on the beautiful things in your life.
* Exercise: It helps you to develop a healthy body and a beautiful mind.
* Goal setting: it gives you direction on where you are going and what to focus on.
* Learning: It enables you to develop the skills and know-how you need to excel in life.
ACTION PLAN: How can you inculcate these habits into your daily routine? What ways can you improve on these habits if you have already developed them? Which of these habits have you mastered? How can you develop the right perspective and attitude towards life?
AFFIRMATION: I am resilient. I am a problem solver. I am blessed and highly favoured.
As a coach, trainer, strategist, speaker and management consultant, Sesan Kareem helps individuals and business entities to develop the belief system and motivation they need in order to succeed, excel and thrive in our ever-changing world.
…As Akeredolu, Kwankwaso, Urhogide, others bag ACPN awards
The Registrar, Pharmacists Council of Nigeria (PCN), Dr Elijah Mohammed, has called on community pharmacists in the country to ensure adequate use of their potentials, saying there are many untapped potentials of practitioners that need to be well enhanced He noted that there is a need for community pharmacists to be involved in public health intervention programmes, adding that the emergence of pharmaceutical care and collaborative drug therapy management which is globally practiced are other areas.
“The current corona pandemic is also a good example, and I commend the community pharmacists for the professional role they have demonstrated so far in various ways to contain COVID-19 pandemic,” he said.
He continued: “The effective use of information and technology system to share ideas on approach to healthcare issues and distribution of essential drugs and commodities, using the system approach, is an area community pharmacists can tap into for more effective delivery, and this can only be achieved through concerted effort”.
However, in appreciation of their commitment and support to pharmacists and pharmaceutical activities in the country, the leadership of the Association of the Community Pharmacists of Nigeria (ACPN) has honoured five eminent personalities with different categories of awards.
Gov. Rotimi Akeredu, Governor, Ondo State, with the National Chairman, ACPN, Dr Samuel Adekola at the event.
Leading the group of recipients was the duo of Governor Rotimi Akeredolu, the executive governor of Ondo State, and Senator Rabi’u Kwankwaso, former governor of Kano State. While others were Sen. (Pharm.) Matthew Uroghide, chairman, Senate Public Account Committee; Senator Sadiq Umar, and late Chief. Rufus Foluso Giwa, the late Ondo business mogul and philanthropist.
The colourful ceremony which took place recently during the 39th Annual National Conference of the ACPN at the International Conference Centre, Abuja had several distinguished pharmacists and other professionals (within and outside the country) in attendance.
Pharm. Deji Osinoiki, presenting the award plaque to Gov Rotimi Akeredolu, as Dr N A E Mohammed, PCN Registrar looks in admiration.
Presenting the awards, the Registrar, PCN, Dr Mohammed congratulated all the recipients adding that they have all demonstrated their pharmacy support, and have equally paid their dues to the development of the country.
While appreciating the ACPN on behalf of other award recipients, the Ondo State governor, Mr Akeredolu, noted that the award would further propel them to do better for humanity, adding that good work deserves commendation.
We will define potentials as the “latent qualities or abilities that may be developed and lead to future success or usefulness.” In the same vein, optimisation refers to the “action of making the best or most effective use of a situation or resource”; or “to make as effective, perfect, or useful as possible”.
Pharm. (Dr) Obalolu Ojo
Consequently, the title of this piece can be elaborated as “How to Make the Best or Most Effective Use of the Latent Qualities or Abilities Inherent in the Training of a Young Pharmacist”. In reality, the theme will be expanded in coverage to include all pharmacists, but with emphasis on young pharmacists.
We are living in a country whose potentials had been largely sub-optimised over the years and the major factor of success for individuals, groups or profession is to live above this environment. From the social science realm, individuals are driven towards self-actualisation, a term described by Abraham Maslow as “the desire for self-fulfilment, namely the tendency for him (the individual) to become actualised in what he is potentially – to become everything one is capable of becoming.” It is this drive that I want to commend to the young pharmacists; to have this self-propelled mechanism to get to the top, the very top of the ladder.
According to Maslow, “What a man can be, he must be.” Simply put, if you are capable of scoring 90 per cent in an examination, you should not be satisfied with a 70 per cent score! Education is best defined as “the training of mind and character”. As a pharmacist, your mind and character have been trained and prepared to take on the world before you and be the best you can be. You are expected to make the full use (exploitation) of your talents, capacities and potentialities; your environment of operation notwithstanding.
Self-actualisers wanted
Maslow also told us that “the story of the human race is the story of men and women selling themselves short”. With experience, we are almost giving credence to this assertion such that it can be said that the story of pharmacists in Nigeria is the story of men and women selling themselves short! We are challenged in all the areas of practice and we are desperately in need of self-actualisers to serve as role models.
A self-actualiser is a person living creatively and fully using his or her potentials. I will urge all to read more about the 13 characteristics of self-actualisers as written down by Abraham Maslow. This knowledge will help you to stay above your environment. The time has come for us to stop talking and complaining about the limitation of our environment. Our attention should now be focused on the individual and his or her desire to be self-actualised.
According to Maslow, “what is necessary to change a person is to change his awareness of himself”. So, let me ask you, since you left school, have you taken a self-examination about who you are and what you have achieved so far? What is stopping you from getting to the highest point of the “life ladder”, that is, a higher purpose of human existence? We complain about lack of employment opportunities or low remuneration package or poor treatment by employers, senior colleagues, and so on; but have we ever bothered ourselves about our collective employability?
The job market is shrinking and getting saturated in a situation that can be called “career climate change”. There are more schools of pharmacy and therefore, more graduates. The oversea option is getting restricted, due to what I will call the “Trump phenomenon” and the COVID-19 pandemic. Our job, as it is constituted now, is more product-centric and this product is treated as a mere commodity in this environment and that will explain why everybody is in it. It is the knowledge and skills of a pharmacist that are not commodities and this is what must be leveraged for competitive advantage.
Attitudinal shift
There is a need for a shift in attitudes, behaviours and pursuit. Our agitation, expectations or drive should no longer be about money at the onset of career development. The emphasis at the beginning should be focused on adding value to the job position or duty to gain recognition and respect in the workplace. The focus should be on how to leverage the knowledge of Pharmacy to create programmes that people want or that employers desire. The future of the profession will not be that of dispensing, distribution or legal restrictions (for example: only pharmacists can open retail pharmacies); rather it will be about deployment of knowledge and skills.
With Pharmacy education, you already have the knowledge as a scientist; but practising the “art” of Pharmacy is what is required in the marketplace. Since you are not well groomed for the practice while in school, you must use your knowledge to acquire the skills and competencies required for success. This acquisition will require patience, determination, humility, sacrifice and more knowledge acquisition. In the process, you must drop the entitlement culture and bloated ego.
The skills required include knowledge of facts and theories relating to the design and manufacture of medicines, ability to communicate effectively, production of pharmacy specific documentation, operation of pharmaceutical instrumentation, knowledge of law and ethics relating to supply of medicines, analysis of medicines, interpersonal skills, ability to work well in a team, problem solving skills, thinking clearly and methodically (creative or strategic thinking),organization and management, commercial awareness among others.
The good news is that the “land is green”. There are so many problems requiring solutions. There are opportunities in commercial, technical, administrative and executive management segments of the practice. The field is open for budding entrepreneurship. Let us think and work more on VALUE ADDITION
A respiratory distressed patient, using an helmet ventilator to breathe.
As a means of bridging the gap in shortage of ventilators for treatment of patients with respiratory distress in Nigeria, the Nigeria Institute of Medical Research (NIMR) in collaboration with foreign scientists have donated 190 helmet-based ventilators to the country.
Of the 190 helmet ventilators, 60 have been deployed to the Federal Ministry of Health, while seven teaching hospitals- Lagos University Teaching Hospital (LUTH); FMC Ebutte Meta; FMC Abeokuta; University Teaching College, Ibadan; Amino Kano University Teaching Hospital; Kano; University of Nigeria Teaching Hospital, Enugu; and Delta State University Teaching Hospital, have received six each of the ventilators.
Fielding questions from journalists at the two days Train-the-Trainers CIRCUM VENT Training organised by NIMR, on Thursday, the Director General, Prof. Babatunde Salako explained the objectives of the programme, which is to provide ventilators in resource-limited settings, along with a streamlined kit of equipment that expands patients treatment options, while safeguarding healthcare providers from exposure to aerosolized SARS-CoV-2.
He said the training is to equip medical trainers with the knowledge of using the newly introduced helmet-based ventilators, while they are expected to return to their institutions to impact their colleagues with the acquired knowledge for optimal usage of the machine.
The NIMR DG also mentioned that the first phase distribution of the equipment is to test the acceptability among patients and to see whether it protects or predisposes users to the infection.
“ A group of American and Nigerian scientists came together to brainstorm on how to assist the nation with the supply of ventilators, then we decided to convert a machine use for treating patients with lungs disease to a non-invasive ventilator. We also designed an helmet to work with the machine.
“The difference between the other ventilator and this new one is that the former usually connect a pipe from the patient’s throat to oxygen, while the new ventilator allows patient to firmly fits the helmet on his head without any disruption in the throat and breath easily through it.
“COVID-19 is still very much with us so we must make every effort to reduce mortality from it.The device is also very useful in preparation for a second wave òf COVID-19 in Nigeria, as they are experiencing in America and Europe presently”, he stated.
Salako also noted another advantage of the new device over the former, saying it is moveable to patients bedside for treatment, while the old one has a heavy machine which can’t be moved.
Previous studies have also given credence to the use of helmets instead of face mask in severely sick patients, as they found that helmets help these patients breathe better than face mask.
In a 2016 study, researchers from the University of Chicago Medicine led an investigation showing that using these helmets instead of standard face masks that cover the nose and mouth helps critically ill patients breathe better and can prevent them from needing intubation with a ventilator machine.
Patients with helmet ventilation also spent less time in the intensive care unit and had better survival, the scientists found.
I often say it, whenever I have the opportunity, that except there is vaccination or injection against deception, the only mitigation or one of the options we have is availing ourselves of nonverbal intelligence. Why? Because over 90 per cent of communication is done nonverbally, according Albert Mehrabian a professor of psychology. Therefore, we need to go beyond verbals, if we must effectively decipher falsehood or deception or, to further stretch it, understand people at a deep level.
In this edition, we shall be looking at a body of knowledge under the canopy of nonverbal intelligence that seeks to profer solution, especially to those who have been victims of deception in document-related matters. If you have ever been swindled by fraudsters through forgery, fake cheques, anonymous letters, disguise etc, then you need to pay attention to this column in the subsequent editions.
My discussion shall be on Forensic Document Examination (FDE) and the objective is not to make the readership forensic experts but to arm anyone with basic knowledge on how to guard against falling into the trap of document fraudsters. This prevents loss of lives and properties.
Definition
Forensic Document Examination, also known as Questioned Document Examination, “involves the evaluation and analysis of various types of documentation for the purpose of detecting forgery, identifying writers and proving or disproving document authenticity or origin”, according Reed Hayes.
The difference between a handwriting analyst and a forensic document expert is that the former evaluates handwriting for the purpose of determining personality, while the latter works with an unknown writing, with the intent of proving authorship or establishing identity. We cannot overemphasise the importance of this body of knowledge in organisations and as a salient tool in national development.
Essential facts
For us to appreciate the value of document examination, there are a few cardinal concepts we need to understand as follows:
No two handwritings are the same. Even if the writings were from the same individual in multiple times, none would be exactly the same as the other. There may be similarities, quite alright; but the moment you observe a writing or signature, for example, looking exactly alike with another from a known or unknown source, it’s a clear sign of fakery.
Regardless of how an individual attempts to forge or doctor a letter or signature, the master pattern (the unique peculiarities in the individuals’ writing or the writing habit) would eventually reveal the authorship of the questioned document. In other words, by the time a professional document examiner evaluates the questioned document and exemplars, the truth is eventually revealed.
The handwriting of an individual can be influenced by several factors such as writing instrument, writing position, age, drugs, injury, mental health status.
The writing of an individual always has some degree of natural variation which prevents writing from being mechanically exact.
When someone attempts to imitate another’s signature or writing, the imitator must eliminate many personal writing characteristics
When a writing has been imitated (simulated) it will bear similarities to the model that is being copied
To prove that two writings were not produced by the same person, fundamental disparities must exist between them which cannot be accounted for by coincidence, accident, disguise, psychological influence or physiological factors.
Instagram (@dipomacjob) (07062456737 Text message)
Mega Healthcare Distribution Centres Plc (MegaMedx), an indigenous pharma healthcare distribution and supply-chain platform, recently announced and flagged off a wealth creation and financing platform for community pharmacists in Nigeria. The first phase, otherwise known as the pilot, is providing a wallet credit of one million naira each to 40 community pharmacists to enable them make purchases of pharmaceutical products and expand their businesses.
Pharm. Adekola Wojuola
In this exclusive interview with Pharmanews, the Managing Director of MegaMedx, Pharm. Adekola Wojuola, explains the vision of the company. He also sheds more light on the Mega Wallet Credit Scheme as well as the ‘Just In time’ concept. Excerpts:
Can you tell us about the vision of MegaMedx and how it plans to impact the Nigerian pharmaceutical space?
The passion of the Mega Healthcare Distribution Centres Plc. is the development of the pharmacy profession in Nigeria. Our vision is very straightforward – we want to enable and enhance the genuine stakeholders in the pharma distribution chain. We want to add value to them. We will enhance them with wealth, trainings and everything that will make the genuine stakeholders to be able to own that sector effectively. That is our vision.
How have you deployed your resources in carrying along the community pharmacists in Nigeria, especially to make them buy into your vision?
As I said, the vision is very big. We have a pan-Nigeria vision and we have started this journey from Lagos. Last year, we had hundreds of interactions – I mean face-to-face, mails, Facebook, webinars and so on.
We have had a lot of interactions with community pharmacists. Every single month, we sponsor a webinar that is run all the way from the University of South Florida to train community pharmacists and I must say that just recently we got a commendation letter from the PSN chairman, Lagos State. He commended us for the sizeable portion of the investment we have made to make sure that pharmacists are being trained on disease management, vaccines, formula development, inventory management and so on. We have been on this for five consecutive months now.
We have also invested a whole lot of money into developing a platform whereby community pharmacists can go in, place their orders and get them just in time. It took a whole lot of resources to get that done. We have also launched the Mega Wallet Credit Scheme where the community pharmacist can get up to a million naira to trade and then return just a small amount of interest.
Tell us more about the Mega Wallet Credit Scheme
We know that credit, when given under the right conditions and to credit-worthy individuals, is actually an agent of economic development. You are aware that the Central Bank of Nigeria is giving loans to the health sector but pharmacists have not been able to access it and so, what we have done as a company is to make sure that, with all these monies running around, we are able to pull some money together and make sure that the community pharmacist is enabled to buy his products in a just – in -time manner. And right there on the platform, he is able to pay for the purchase.
Instead of out of pocket, it is now out of wallet. That wallet has been credited and it is gradually debited as the card is being used. Every first day of the next month, it is topped up and the cycle just continues, as long as these monies are returned in compliance with the conditions.
Eventually, our goal is that a community pharmacist that has just one outlet today could earn a profit of 3.5 million naira by the end of the year. We have demonstrated this financial model and in two years, the pharmacist was able to save up enough money to open another outlet.
The more pharmacies that belong to pharmacists, the more we are able to protect that space and ensure that the drug industry in Nigeria is being run by professionals.
Are there any constraints you are facing as a group in actualising your vision?
You know that everything new has its own challenges. This is an online platform and the average medical practitioner might not be too comfortable using the online platform for ordering products. Some of us are already using Jumia and some other Apps but some have serious reservations about the use of online platforms.
However, what we have been able to see in the last one month is that this inertia of people adopting a new way of doing things can be overcome. If you cannot get online, you can send your orders through emails or call our representatives and business development managers or our customer service representatives. We are all here to help you. We run monthly webinars where we do demonstrate how you can use the platform.
Your company keeps talking about universal best practice. How do you intend to apply this principle in rewriting the story of the Nigerian pharmaceutical space?
Anything that is not global best practice can only run for a short while. The reason is that the world has become a global village. Nothing is done in isolation. For example, the United States election is so popular in Nigeria because everybody is following global trends with the help of technology.
International best practice implies that a pharmacist does not have to order cartons and cartons of drugs because a pharmacy is not a warehouse. There is a concept we call “Just In Time”. This concept is used in eateries where they have estimates of foods they are supposed to sell in a day. This is a way to avoid wastage. Order what you need today, today and leave tomorrow’s needs for tomorrow. What we are trying to do is to improve the practice of community pharmacy in Nigeria.
What areas in the Nigerian health sector do you think government needs to fix for better service delivery?
I would say that there are many weak points but I would like to focus on pharma distribution. It is one of the weakest points. Sustainable development goals 2030 has seen the whole world coming to agree on a 17-point agenda which is supposed to touch every of the 7 billion people living on this earth.
There is a plan to make sure that the world is a better place by 2030. The number 3 of these goals is “health for all”. Under this goal, one of the themes is “Developing more partnerships and accountable institutions”. We have to institutionalise the distribution of drugs in Nigeria. I appreciate the fact that the government is doing a lot in that regard. The national drug distribution guideline is already making efforts to take away the scourge of markets everywhere and entrench an orderly way of allowing products come into Nigeria. As they come into Nigeria, we know where they are going and at the end of the day, we can track every single pack of drug being distributed in the country.
In a nutshell, what culture is Mega Healthcare Distribution Centres Plc trying to entrench in the Nigerian pharmaceutical industry?
The culture we are trying to entrench is the culture of excellence; the culture of doing things with the right intent and the right approach. We are in business to develop the Nigerian community pharmacist and that has been our goal right from day one.
If the pharmacist is not developed, some other people who are not trained to do this job would hijack the space and it would be very sad if we are not able to get a regulated practice. The more we entrench excellent ways of doing things, the more we employ and develop our people and the more we use technology, which is the process to drive what we want to achieve.
The biblical book of 1 Samuel 16:14-16 contains an interesting narration that vividly exemplifies the psycho-therapeutic power of music. From that account, it is very evident that King Saul was already paranoid with the presence of the evil spirit that was tormenting his soul. He was in dire need of help and his officials knew that the power of music could solve his problem.
The experience of King Saul lends credence to the fact that music plays a significant role in psycho-therapy; it has a way of affecting mood, cognition and behaviour. It can act as a healing tool when properly applied. This is the reason most religions, especially Christianity, is music-inclined. It is believed that affirmative and inspirational songs have the power to bring human dreams and aspirations to fruition.
Against all the odds and vicissitudes of an uncertain life, these religious devotees are often reassured of hope and victory through the songs they sing. As far as they are concerned, God, who typifies their greatest hope, will not allow them to be crushed by the problems of life and so, their faith and confidence is beyond destruction.
According to the Wikipedia, “Music therapy is an evidence-based clinical use of musical interventions to improve clients› quality of life. Music therapists use music and its many facets— physical, cognitive, emotional/psychological, social, aesthetic, and spiritual— to help clients improve their health in cognitive, motor, emotional, communicative, social, sensory, and educational domains by using both active and receptive music experiences. These experiences include improvisation, re-creation, composition, receptive methods, and discussion of music.”
Mr Patrick Iwelummor
Music transcends time and is present in all communities throughout the world. Given the universal nature of music, music therapy is uniquely able to reach individuals across all backgrounds and ages. It does not require any previous knowledge for individuals to meet their goals and be impacted. Music therapy provides individualised treatments to help treat individuals with disabilities, injuries, illnesses or to improve their well-being.
People suffering from emotional issues such as heartbreak, loss of a close relation, job or property have shown remarkable improvement using music therapy. Depression, which comes with all sorts of negative thoughts, can be adequately managed through the application of music therapy. The popular Christian song, “It Is Well With My Soul”, originally written by Horatio Spafford, has remained a reassuring source of hope, even in the face of the worst situations of life. Losing all his daughters in the famous wreck of the SS Ville du Havre, Spafford summoned the emotional fortitude as he sailed to England to meet up with his surviving wife. He wrote the song while on that trip.
Many people have overcome their depressive states listening to this particular hymn. The reasons are not far-fetched. Our sub-conscious minds usually gives way to affirmations that we repeatedly declare until they become a part of us. Thus, God and all the forces of the universe create the enabling opportunities for those affirmations or aspirations to come to fruition.
Healthline.com corroborates the psycho-therapeutic effect of music in balancing mood and boosting a positive mental outlook. According to the website, “New research shows that even sad music can lift your mood, while other studies suggest music can boost happiness and reduce anxiety. From the drumbeats of our ancient ancestors to today’s unlimited streaming services, music is an integral part of the human experience. Researchers have pondered the possible therapeutic and mood boosting benefits of music for centuries. Even sad music brings most listeners pleasure and comfort, according to recent research from Durham University in the United Kingdom and the University of Jyväskylä in Finland, published in PLOS ONETrusted. Conversely, the study found that for some people, sad music can cause negative feelings of profound grief. The research involved three surveys of more than 2,400 people in the United Kingdom and Finland, focusing on the emotions and memorable experiences associated with listening to sad songs. The majority of experiences reported by participants were positive”.
The famous Swedish group ABBA, in one of their international hits, shed more light on the power of music thus:
“… Thank you for the music, the songs I’m singing.
Thanks for all the joy they’re bringing
Who can live without it, I ask in all honesty
What would life be?
Without a song or a dance or a dance, what are we?
So, I say, thank you for the music
For giving it to me…”
The psycho-therapeutic power of music cannot be overemphasised in a world constantly molested by troubles of all shades. So, whenever there is a tense, sad, unpleasant or frustrating situation, a song of hope or a chant of victory can turn the tides in our favour. Debasish Mridha has said it all – “Music can heal the wounds which medicine cannot touch.”
Throughout the history of mankind, healthcare delivery has witnessed the extraordinary contributions of women, whose passion to save lives has become an enviable legacy. From the contributions of Florence Nightingale to nursing to the heroic acts of Clara Barton which led to the establishment of the American Red Cross, the history of healthcare is indeed replete with women whose impact is unquantifiable.
In this regard, the immense impact of Temie Giwa-Tubosun in healthcare in Africa is a reminder that history has a way of repeating itself. What began as a yearning and passion to save lives for Temie has now evolved to a fully blown social enterprise affecting thousands of lives across Africa.
Temie Giwa-Tubosun
Temitope Giwa-Tubosun, popularly known as Temie, is a Nigerian-American health manager and founder of LifeBank (formerly called One Percent Project), a Nigerian-based social enterprise, working to improve access to safe blood transfusions and other essential medical products across Africa.
In Nigeria, blood shortages are responsible for innumerable complications for women immediately after childbirth and contribute to the deaths of 152,000 anaemic children and 37,000 pregnant women each year. The World Health Organisation (WHO) has identified postpartum haemorrhage as a major cause of maternal mortality worldwide, with women in developing countries at a higher risk.
Temie started LifeBank in 2016 to bring vital medical supplies like emergency medical oxygen cannisters, platelets, plasma, vaccines and most especially blood, to people who need them, when they need them and in the right condition. Since its launch, the company has transported more than 20,000 units of blood and other medical products, served about 500 hospitals, engaged over 6000 donors, and saved about 8000 lives.
Background and education
Temie was born on December 1985 in Ila Orangun, Osun State, Nigeria. The fourth of six children, Temie’s father was a university professor and her mother was a secondary school teacher. She grew up in Ila, Ilesha, and in Ibadan until she was 15. Five years earlier, when she was ten, her parents won the US Diversity Immigrant Visa and left for the United States with the three older siblings. In 2001, at 15, Temie left to join them with her two younger siblings.
Temie attended Osseo Senior High School, Minnesota, and graduated in 2003. That same year she gained admission to Minnesota State University, Moorhead, and graduated in 2007 with a B.A degree in Political Science. In 2008, she was admitted to the graduate school at Middlebury Institute of International Studies, at Monterey, from where she received her master’s degree in Public Administration, Health Systems Management and International Management in July 2010.
Journey to LifeBank
In 2009, after Temie’s first year in graduate school, she returned to Nigeria for the first time since 2001 for her internship in Abuja. The internship programme lasted three months, during which she had an encounter with a poor mother, called Aisha, whose protracted labour convinced her of the problem of maternal mortality in Nigeria.
Inspired by this encounter, she went for a graduate fellowship at the World Health Organisation in Geneva, Switzerland, in January 2010 which lasted till July of that year when she graduated from Middlebury Institute of International Studies at Monterey. In August 2011, she began a fellowship with the Global Health Corps, and spent the next 12 months at Mbarara, Uganda, working with the Millennium Villages Project, a programme of the United Nations and Millennium Development Goals.
In May 2012, Temie founded a non-governmental organisation called One Percent Blood Donation Enlightenment Foundation or One Percent Project, with the aim of ending blood shortage, using an efficient distribution network of blood in blood banks in Nigeria. The initiative was involved in educating people on the importance of blood donation and to help them overcome fears, prejudice, myths and apathy in blood donation.
Temie’s experience with WHO, UN and the One Percent Project was the harbinger to her establishment of LifeBank in January 2016, about two years after the complicated child delivery of her first child and seven years after her encounter with Aisha, the young mother she had met in Kano, who nearly died after three days of labour.
LifeBank, which started as a healthcare technology and logistics service company, has grown to become an important player in Nigeria’s healthcare industry. The company has currently scaled up its operations to other African countries, after receiving multiple awards, grants and funding.
In 2019, LifeBank started using drones to deliver emergency medical supplies in Ethiopia. The company also has built a system that uses block chain technology to record and preserve the integrity of information about the blood supply.
LifeBank’s ambitious mission is to save a million lives across Africa in 10 years and to reach all of Africa, India, Southeast Asia, and South America, to deliver critical supplies around the clock.
Awards and recognitions
In May 2017, Temie was selected as part of “six entrepreneurs who demonstrate the positive role women are playing in creating opportunities and preparing the region for the Fourth Industrial Revolution” by the World Economic Forum on Africa.
That same month, she was listed in the annual Quartz African Innovators List of “more than 30 Africans” who are “taking leadership and control in a wide range of fields”, including finance, healthcare, education, agriculture, design and many other fields.
Mark Zuckerberg, founder of Facebook, on his first visit to Nigeria in 2016, acknowledged the work Temie is doing, saying: “If everyone had the opportunity to build something like this (LifeBank), then the world would be a better place… I’ve been to a lot of different cities, people around the world are trying to build stuff like that…”
On 16 November, 2019, Temie was named the winner of Jack Ma’s Africa Netpreneur Prize worth $250,000. The prize-giving ceremony, which held in Accra, Ghana got applications from more than 10,000 startups from 50 African countries.
In addition, Temie has been announced as the 2020 Laureate for Sub-Saharan Africa, winning the sum of US$ 100,000 in grant at the 2020 edition of Cartier Women’s Initiative. The Cartier Women’s Initiative, which was founded in 2006, has helped women over the years to reach their full potential by highlighting their achievements, while providing them with the necessary financial, social and human capital support in growing their businesses and leadership skills.
Temie is happily married to Kola Tubosun who is a writer and linguist. They live in Lagos with their son, Eniafe.
The just-concluded 93rd national conference of the Pharmaceutical Society of Nigeria is a fitting proof of the truism expressed by the French statesman, Charles de Gaulle that “Nothing great will ever be achieved without great men, and men are great only if they are determined to be so.” Indeed, to many pharmacists in Nigeria and beyond, the successful holding of the conference tagged “Omoluabi 2020” not only achieved the conventional purpose of helping to reposition them for better and more effective service delivery but also symbolises the proverbial “light” at the end of the tunnel of what has been a tumultuous year.
Against the odds of the COVID-19 pandemic and the EndSARS protests, the momentous gathering was held in Osogbo, the Osun State capital, from Monday 9 November to Friday, 13 November, 2020, after being postponed from the 2-7 November date previously planned. Incidentally, the annual conference of the PSN is adjudged to be the largest single gathering of pharmacists in the West African sub-region and this year’s event, despite doubts and apprehensions caused by the global pandemic and security concerns in the country, measured up to this rating as it witnessed a large turnout of pharmacists from all parts of the country.
This is a testament to not just the exceptional sagacity of the national leadership of the PSN, led by Mazi Sam Ohuabunwa; the Central Planning Committee (CPC), led by Pharm. Abass Sambo; as well as the Local Organising Committee, but also the indefatigable commitment of Nigerian pharmacists towards advancing their profession in the interest of the country’s health sector and the entire populace.
The theme of this year’s event, “Technological Revolution: Adaption to Pharmaceutical Manufacturing, Pharmacy Practice and Regulation”, was particularly apt and commendably justified. Participants at the conference were enlightened on how to leverage the dynamics of technology to overcome the challenges of the global pandemic and ensure greater productivity and profitability in their practice in the face of the emerging era, rightly dubbed “the new normal”. The choice of an erudite innovator, professor of pharmacy and vice-chancellor of Nnamdi Azikiwe University, Awka, Anambra State, Prof. Charles Esimone, as the keynote speaker could not have been better as he expertly dissected the subject, eliciting thunderous applause from delegates at the conference.
It is also important to note that this year’s conference was particularly unique as it was the first hybrid conference of the PSN, allowing for both physical and virtual participation. This singular innovation made it possible for Nigerian pharmacists across the globe to follow live proceedings at the conference. We applaud the PSN leadership and the conference planning committees for making this novel initiative a success, and accordingly leading the way in inculcating and applying the theme of the conference.
Also noteworthy is that the annual gathering was held for the first time in Osun State, and the state no doubt, gave a good account of itself as the Governor, Mr Gboyega Oyetola not only graced the event but had nearly all members of his cabinet – consisting of the deputy Governor, Secretary to the State Government and several commissioners – present. Kudos must be given to the LOC and others who made this possible.
We equally commend the peaceful conduct of the elections into some executive positions of the PSN, namely, the national secretary, the treasurer, and the editor–in- chief. The Young Pharmacists Group also had elections to constitute new members of the executive and must be commended for the seamless conduct of their exercise.
Generally, from all indications and sampled opinions of the participants, the conference is adjudged a resounding success, despite the limitations placed on it by the pandemic, which reduced physical attendance and thus diminished the carnival-like fanfare commonly associated with PSN national conferences.
Despite the success of the event, however, we observed that a few aspects of the organisation could have been done better. One of this was the pre-conference publicity. This was inadequately handled. The posters announcing the conference, which in previous conferences, were printed and pasted conspicuously at strategic places were nowhere to be found this year. This created a picture of uncertainty, especially in the minds of exhibitors, as many thought the conference would not hold. We believe that if this had been properly handled, coupled with proper event marketing, the number of exhibitors at this year’s conference would perhaps have been more.
Another noticeable lapse was also the late arrival or paucity of conference materials for participants and delegates. Many delegates spent time at the registration stands waiting to get conference materials. This can be improved on. While some delegates had tags which were hand written, there was also the absence of tags to identify pressmen and press coverage was noticeably poor. For an event such as the PSN conference, notable media houses should be invited and adequate provisions made to identify them. This way, good publicity will be given to the event.
Also to be noted for future conferences is the issue of time management. Many participants were not pleased that most of the scheduled activities at this year’s conference either started or ended late. This gives the impression of inadequate organisation, especially to people who are connecting to the event from outside the venue.
Moreover, although the COVID-19 challenge limited physical attendance at the conference, we believe that the non-proximity of an airport to Osogbo affected attendance as many who would have loved to attend the conference could not do so by road especially given the security situation in the country. This, we note, was clearly beyond the control of the organisers. The PSN may consider the proximity of an airport when deciding on the venue of future conferences.
Dr Teresa Pounds is a specialist in critical care/nutrition support and also a board certified nutrition support pharmacist. A holder of PharmD, Pounds is the programme director, Pharmacy Residency Postgraduate Programme, at WellStar Atlanta Medical Centre (WAMC) in Atlanta, Georgia, USA. In this exclusive chat with Pharmanews, she speaks on how to advance different aspects of pharmacy practice, with special emphasis on the roles of consultant pharmacists in healthcare delivery, as the global community battles circulation of counterfeit medical and pharmaceutical supplies in hospitals. She also highlights the place of passion in successful pharmacy practice. Excerpts:
Can you tell us briefly about yourself?
I started my pharmacy career as an outstanding student on a four-year academic scholarship at Spelman College, an Ivy League institution in Atlanta, Georgia. I graduated with the highest academic honours (cum laude); and continued my excellent academic career at Mercer University in Atlanta, Georgia, as a dean’s scholar.
On the completion of my first year postgraduate residency training, I forged ahead to complete my second year postgraduate residency training in Nutritional Support at the Georgia Baptist Hospital.
WAMC is a part of the WellStar Health System, which is one the largest health systems in Georgia. WellStar Health System is a non-profit Level 1 trauma centre and teaching hospital that is well known for its commitment to the community and innovative patient care. It comprises 11 hospitals, hundreds of healthcare sites, and tens of thousands of healthcare staff.
Prof. Teresa Pounds
The WellStar Health system continues to be known for providing care to our patients, regardless of their financial wellbeing, and is dedicated to delivering world-class healthcare. I have been a crucial facet in helping to deliver this institution’s vision on a national level, because I have played an integral role in collaborating with principal stakeholders to bring the PharmD programme to Nigeria.
This was largely due to my enduring prowess in many pharmacy schools’ programmes across the United States universities, such as the Mercer University, Philadelphia College of Osteopathic Medicine, South University, and many more. Through my expertise, I have managed to not only practise clinical pharmacy, but also instruct thousands of pharmacy residents and students over the years.
I am very passionate about pharmacy professionals’ standards and educational excellence in the United States and my home country, Nigeria. In my home country, I have collaborated with the Association of Nigerian Physicians in the Americas (ANPA) and a group of Nigerian and US pharmacists for a medical mission to provide medical care for Abuja residents. I supervised the medication arm of the medical mission, organisation of the donation, transportation of medical supplies, and managing the financial support from private individuals, pharmacies, and hospitals in Abuja.
The WAMC residency programme has the pleasure of being a part of the Accreditation Council for Graduate Medical Education (ACGME) programme. This collaboration has allowed me the opportunity to minimise the gap between physicians and pharmacists. Pharmacists and physicians are working together to enhance the management of patient medication and ultimately improve patient outcomes. Consequently, this would provide my residents with the platform to work together with other medical residents.
Furthermore, I have been fortunate to hold several academic appointments in the US and beyond, as I actively work with different national and multinational organisations that manage the advancement and development of pharmacy practice and education, pharmaceutical care initiatives, implementation and development of collaborative frameworks within interdisciplinary organisations to underpin the advancement of pharmacy practice in Nigeria through medical missions, educational workshops, curriculum development and preceptorship.
Additionally, due to my experience with medical nutrition, I have gradually developed the passion to advance my medical nutritional skills in the United States and beyond.
I am very passionate about pharmacy education, standardisation protocols, curricula development, appraisal, and accreditation processes and procedures. I am honoured to be able to help my home country, Nigeria in the journey towards the evolution of pharmaceutical care standardisation and better healthcare for all.
Being an experienced practitioner of clinical pharmacy, would you say the consultant title for pharmacists is out of place, as being claimed by Nigerian medics?
I would say the consultant title for pharmacists is not out of place since this title supports patient care through the safe, evidence-based, cost-effective use of medicines and, most of all, it is very important. Precisely, individuals holding this role lead interdisciplinary development of medicine use policies and procedures. These policies and procedures help to set a plan of action for using a particular drug for the desired clinical outcomes. In other words, the policies and procedures help to formulate guidelines for using a particular drug. They also ensure that drugs used in the medical facilities are acquired from renown and quality suppliers.
Today, the world is filled with counterfeit products and hospitals should not make the mistake of buying nonstandard drugs or hospital equipment. However, due to the expertise of consultant pharmacists, they can help to identity drugs that meet the standards of preparation and whose use has been found to be effective. These consultants can also be involved in drug preparation for patient administration.
Additionally, they oversee the role of drug distribution in their respective hospitals. In this case, they ensure that all hospital departments are supplied with the right amount and types of drugs, depending on the cases and the dosages required.
Nevertheless, they are expected to evaluate the documentation of adverse effects and behaviour of the medication for patient or drug review. It is worth understanding that some drugs cause adverse effects than others, due to their variability in the pharmacodynamics and pharmacokinetics. Besides, genetic, pharmacological, and immunological factors have been known to contribute to the adverse effects.
At times, patients may fail to respond to their treatment regime and these consultants have a role in facilitating the transition of regimes with little or minimal adverse effects
A critical review of pharmacy practice shows there are differences in practice across the globe. As a professor of pharmacy, how can this gap be bridged?
By uniting pharmacists with pharmaceutical scientists, to build on the importance of healthcare knowledge using evidence-based medicine. Also, introducing community pharmacists to different pharmacy disciplines that can be career transition options. Examples include clinical pharmacy, entrepreneurship, medical science liaison, and others.
Additionally, other strategies that can be put in place include the implementation of legislation or policies on clinical pharmaceutical requirements for accreditation or hospital licensing, implementation of policies that support the increment of pharmacy training and educational reforms, integrating clinical pharmacists to diverse care teams, developing and integrating clinical documents tools in healthcare facilities, ensuring that practice sites have qualified clinical preceptors and strengthening regional and national pharmacy and clinical associations.
As an expert in nutritional support and from your experience with COVID-19 patients, what would you say is the place of nutrition in patients’ outcome?
Good nutrition is important in a patient’s response to the infection. A patient needs to eat and drink so that he or she can support the body’s ability to fight the virus and support the body’s immune function. Eating of high calorie and high protein foods enhances the body to maintain its metabolic functions and body weight during the critical time. Depending on the patient’s specifics, a nutritional support regime that is tailored specifically to each individual patient can help to replace nutritional deficiencies and speed up the recovery process.
Hospitalised patients who contract the virus are at a heightened risk for malnutrition. The novel COVID-19 has shown to cause loss of taste, smell, and appetite, which can lead to weight loss and muscle wasting. Nutrition regimens can be formulated using the patient’s specific nutritional needs to help with weight gain and muscle loss. Patients who receive proper nutritional support while being treated for COVID-19 have a decreased risk for further complications and show faster times to recovery.
My passion for medical nutrition can be traced back to the interest I had in the nutrition aspect of food while I grew up. Precisely, my family was strict on the nutritional value of food that was consumed in the household. Throughout my profession, I have come to learn the true essence of nutrition for in-patients. Primarily, good nutrition is essential for preventing malnutrition, degenerative illnesses, and promoting the general well-being of patients. As such, it has been proven time after time that nutrition plays a big part in patients’ outcomes through nutrition programmes that shorten the duration of stay at the hospital.
Having made valuable contributions in the areas of pharmacotherapy and the pharmaceutical sciences, what would you describe as the challenges impeding best practices in these areas?
As technology and research advance in the pharmaceutical sciences and pharmacotherapy, many other pharmacological methodologies within precision medicine are being developed with great promise for clinical application and therapeutic outcomes. One of the challenges is the ability to determine which biomarkers and technologies are most informative or applicable to the patient’s care. Also, it has become relatively challenging to develop new drugs that provide cure to today’s most prevalent and incurable illnesses. As a result, this has called for continued investments from governments and stakeholders to carry out extensive research that will provide long-term solutions or cure for these diseases.
On the other hand, the expectations of pharma customers are quickly rising as the commercial atmosphere continues to be ruthless and harder because patients expect the treatment and therapies to be effective and extremely reliable. On this note, these patients have continued to demand evidence of clinical results associated with drugs to ascertain the claims made by pharmaceutical companies. Nevertheless, scientific productivity has become stagnant and lacklustre over time holding new drugs at a constant level.
Still on COVID-19, how would you assess the global management of the infection?
On testing of COVID-19, there are still inadequate testing kits in some countries, making the testing capacity too low; yet there might be more patients that have acquired the diseases, and they are spreading it.
Contact tracing of COVID -19 patients is being done. Still, countries with a larger population are experiencing challenges with this mechanism as not all of the people who came in contact with the patient are able to be traced. Some of them may decide not to report, making the exercise harder.
Wearing masks has been termed as one of the best methods of minimising the disease’s spread, but some countries haven’t made this guideline compulsory for each citizen. It is worth understanding that facemasks help to prevent the passage or spread of the virus from one individual to another. Precisely, when someone sneezes, coughs, or talks, facemasks act as a control strategy that prevents the virus from spreading to other people.
In what ways can pharmacists upgrade their roles in the critical care of patients?
For pharmacists to upgrade their role, the curriculum courses must provide them with full knowledge of addressing the patient’s problems and develop a plan for him or her.
Pharmacists need to contribute to rounds, managing medication therapies for their patients, and participating in codes and medical emergencies. Also, they should collaborate with senior pharmacists and mentors to address the patients’ needs, redefine their roles, and the scope of their activities, and identify areas in practice that need further training or insights from knowledgeable individuals.
As an accomplished pharmacist, what is your advice to young pharmacists aspiring to be like you?
Not only is the pharmacy profession growing relatively fast, it is gradually becoming very competitive because the drug market is continually seeking cost-effective and effectual drugs that meet medical needs of the patients. As such, obtaining the PharmD is now one of the key requirements for obtaining a job and meeting the requirements needed to execute these tasks. Many universities offer the PharmD degree programme to pharmacists who are still practising in their own countries to keep them up to date with the current pharmaceutical trends.
However, young pharmacists must be very passionate about pharmacy education because it takes effort to blend different aspects of learning and understand the logic behind the magic in pharmacology. Thus, they must be mindful of what they do each moment because it adds up to who they become. Learning should never stop even after graduating because new and scholarly knowledge is put to the world every day.
Therefore, young pharmacists should take the initiative of reading new research studies and keeping up with information about new drugs in the market. They should also consider other ways to make themselves more marketable in this increasingly saturated market. Pharmacists should consider additional degrees like a Master of Business Administration or Engineering.
President John F Kennedy once said, “Ask not what your country can do for you, but what you can do for your country.” Hence one must have goals on what you need to do and accomplish as a pharmacist. With such convictions, one is likely to put more effort in their profession and carry out researches that help to solve different issues in society.
Finally, mentorship is very important because it provides one the stage to learn their mentor’s skills and further share their knowledge. Therefore, finding the right mentor can be a powerful tool for professional growth because it provides the road map to success and a feeling of togetherness.
When choosing an effective mentor, one should consider people who have made significant change in society or seek guidance from people we perceive successful in what we desire the most. An effective mentor should be someone who has enough time to dedicate to develop a positive mentorship relationship and follow up with those who look up to him. As a result, one should avoid choosing mentors solely on popularity or monetary success.
The Medicines and Healthcare products Regulatory Agency has approved the Pfizer/BioNTech vaccine and concluded it is both safe and effective.
The MHRA is an executive agency of the Department of Health and Social Care in the United Kingdom that is responsible for ensuring that medicines and medical devices work and are acceptably safe.
It will start to be rolled out from next week Care home residents, health and social care staff, elderly and clinically extremely vulnerable among first to get it.
Britain on Wednesday became the first country to approve Pfizer-BioNTech’s COVID-19 vaccine for general use and said it would be introduced next week.
“The government has today accepted the recommendation from the independent Medicines and Healthcare products Regulatory Agency (MHRA) to approve Pfizer-BioNTech’s Covid-19 vaccine for use,” the department of health said in a statement.
“The vaccine will be made available across the UK from next week,” the statement said, with priority groups including care home residents, health and care staff. (AFP)
– As Falabi, Madehin, Ilomuanya win PSN 2020 elections
As the race to fill the vacant offices of the national secretary, national treasurer, and national editor-in-chief of the Pharmaceutical Society of Nigeria (PSN), ended during the Annual General Meeting of the Society, which took place at the De Distinguished Event Centre, Osogbo, Osun, during the just concluded “Omoluabi 2020” conference, Pharm. Olumide Akintayo, former president, PSN, has urged winners of the election to make good use of their offices and be magnanimous in victory.
The trio of Pharm. Olugbenga Falabi, a contestant for the office of national secretary; Pharm. Olanrewaju Gafar Madehin, a contestant for the post of the treasurer; and Pharm. (Dr) Margaret Ilomuanya, a contestant for the post of editor-in-chief emerged winners of the keenly contested 2020 PSN elections and were returned elected.
Speaking further, Akintayo, who conducted the oath of office on the constituted members of the national executive council, further urged them to hit the ground running, adding that there were no winners, nor losers in the election.
Declaring the results, the electoral commitee chairman, Pharm. Peter Iliya, a director at the Pharmacists Council of Nigeria (PCN) declared the trio returned and elected, having garnered the maximum number of valid votes in the elections.
According to the election umpire, Falabi polled 490 votes to defeat his opponent, Pharm. Livinus Emeronye, who had 117 votes.
PIX: A cross-section of the constituted members of the executive of PSN, led by the President, Pharm. Mazi Sam Ohuabunwa, being sworn into the office by the former president, PSN, Pharm. Olumide Akintayo, at the Closing Banquet of the 93rd Annual PSN Conference, held in Osogbo, Osun State recently.
He added that Madehin who contested for the position of treasurer also polled 430 votes, to defeat his opponent, Pharm. Emeka Adimoha, who had 173 votes; while Ilomuanya had 372 votes to defeat her opponent, Pharm. Dauda Dangiwa, who had 242 votes.
In their reactions, the newly elected officers who were beaming with smiles promised to serve diligently, adding that they were grateful to the electorates for having trust in them, as well as the leadership of the PSN for creating an enabling environment to conduct a free and fair election.
According to Falabi, the newly elected secretary, “The opportunity to work has presented itself again, and we are ready to bring the PSN now closer to the people. We will improve on the communication between the society and the pharmacists and we will ensure that people know what PSN is doing at every point in time.”
Also speaking, the duo of Madehin, the newly elected treasurer and Ilomuanya, editor-in-chief, promised to bring their experiences to bear in discharging their duties, saying they both dedicate their victories to their primary constituencies, the ACPN and NAPA, respectively.
As Nigerians join the rest of the world to celebrate the World AIDS’ Day, the World Health Organisation has said in 2020, HIV has claimed almost 33 million lives so far.
The global health body says HIV continues to be a major global public health issue, however, with increasing access to effective HIV prevention, diagnosis, treatment and care, including for opportunistic infections, HIV infection has become a manageable chronic health condition, enabling people living with HIV to lead long and healthy lives.
In a statement obtained from the agency’s site, it was revealed that an estimated 38 million people were living with HIV at the end of 2019.
“As a result of concerted international efforts to respond to HIV, coverage of services has been steadily increasing. In 2019, 68 percent of adults and 53 percent of children living with HIV globally were receiving lifelong antiretroviral therapy.
“A great majority (85 per cent) of pregnant and breastfeeding women living with HIV also received ART, which not only protects their health, but also ensures prevention of HIV transmission to their new-borns,” WHO said.
However, not everyone is able to access HIV testing, treatment, and care. Notably, the 2018 Super-Fast-Track targets for reducing new paediatric HIV infections to 40,000 was not achieved. Global targets for 2020 are at risk of being missed unless rapid action is taken.
Over 33million have died of HIV says WHO
It also said that at the end of 2019, an estimated 81 per cent of people living with HIV knew their status. 67 per cent were receiving antiretroviral therapy (ART) and 59 per cent had achieved suppression of the HIV virus with no risk of infecting others.
The body added that by June 2020, 26 million people were accessing antiretroviral therapy, maing a 2.4 per cent increase from an estimate of 25.4 million at the end of 2019. By comparison, treatment coverage increased by an estimated 4.8 per cent between January and June of 2019.
According to the World Health Organisation, several studies confirmed that if an HIV-positive person is taking ART and is virally suppressed, they do not transmit HIV to their uninfected sexual partners.
The agency advised that all people living with HIV should be offered ART with the main aim of saving lives and contributing to reducing HIV transmission.
According to a 2018 Nigeria HIV/AIDS Indicator and Impact Survey published on UNAIDS, the prevalence of HIV among adults age 15-64 years was 1.4 percent, 1.8 percent among females, and 1.0 percent among males.
The analysis also shows that the prevalence of HIV among children age 0-14 years was 0.1 percent.
“Prevalence of viral load suppression among PLHIV age 15-64 years in Nigeria was 43.1 percent, 45.5 percent among females and 38.8 percent among males.
“HIV prevalence was the highest among females age 35-39 years at 3.1 percent and the highest among males age 50-54 years at 2.3 percent. The HIV prevalence gender disparity between females and males was greatest among younger adults, with females age 35-39 years (3.1 percent) having 2 times the prevalence of males in the same age group (1.4 percent).
“Among adults age 15-64 years, HIV prevalence by state ranged from 4.8 percent in Akwa-Ibom, 1.4 per cent in Abuja and Benue States to 0.3 percent in Jigawa and Katsina States.
“Viral Load Suppression (VLS) among People Living with HIV/AIDS (PLHIV) was the highest among males age 55- 64 years at 52.3 percent and the highest among females age 45-54 years at 53.7 percent. The VLS gender disparity between females and males was greatest among those aged 0-14 years, with females age 0-14 years (31.7 percent) almost 3 times more likely to have viral suppression compared to males in the same age group (10.6 percent),” the analysis showed.
According to the analysis, 90 percent of PLHIV are expected to know their status by 2020, 90 percent diagnosed with HIV infection will receive sustained Antiretroviral Therapy and 90 percent of all people receiving ART will have viral suppression.
“The diagnosis carried out among PLHIV aged 15-64 years, 46.9 percent self-reported knowing their HIV Status or had detectable ARVs in their blood, 40.9 percent of males and 50.3 percent of females,” it noted.
On treatment, the data shows that among PLHIV age 15-64 years who knew their HIV status, 96.4 percent self-reported being on ART or had detectable ARVs in the blood, 97.8 percent of males and 95.8 percent of females.
The body says currently there is no cure for HIV infection. However, effective prevention interventions are available: preventing mother-to-child-transmission, male and female condom use, harm reduction interventions, pre-exposure prophylaxis, post exposure prophylaxis, voluntary medical male circumcision (VMMC) and antiretroviral drugs (ARVs) which can control the virus and help prevent onward transmission to other people.
As an affirmation to the progress made in the war against HIV/AIDS in Nigeria, the National Coordinator of the Network of People Living with HIV/AIDS in Nigeria (NEPWHAN) Mr Abdulkadir Ibrahim has attested to the fact that patients are responding to treatment, as some of their viral loads are now undetected.
Nonetheless, this does not connotes victory over the infectious disease, as the Joint United Nations Programme on HIV/AIDS, UNAIDS has disclosed that over 12 million people living with HIV still do not have access to life-saving HIV treatment.
Speaking on the occasion of World AIDS Day, WAD 2020, the Executive Director of UNAIDS, Winnie Byanyima, said inaccessibility to essential services made about 1.7 million people became infected with HIV in 2019 and those factors are still unaddressed today.
Ibrahim, who has been on antiretroviral treatment for 11 years, appreciated the Nigerian government and the government of the United States for their magnanimity in the provision of ARVs for People Living with HIV/AIDS.
In his remarks during the World AIDS Day Programme, organised by the National Agency for the Control of AIDS, NACA with the launch of Strategic Document and an Annual Lecture, on Tuesday, at theTranscorp Hilton Hotel, Abuja, the National Coordinator NEPWHAN affirmed the efficacy of ARVs in the country.
Abdulkadir Ibrahim
“I am a living testimony that HIV treatment is working as I have being on antiretroviral therapy for 11 years.
“I thank Nigeria Government and the Government of United States for their support for People Living with HIV/AIDS”, he stated.
He however stressed the need for more support, saying lack of funding for healthcare has predisposed several countries to the infection, of which they are still grappling with till date.
In his statement on the theme of the WAD 2020, “Global Solidarity and Shared Responsibility”, Ibrahim called for more involvement of all stakeholders in the campaign against HIV/AIDS, noting that no one should be left behind.
“It is within this context that NEPWHAN commenced the implementation of the community-led monitoring initiative in Nigeria by collecting quantitative and qualitative data among people living with HIV.
”While we look forward to continued collaboration, working and partnering with everyone for the interest of people living with the virus and ending HIV by 2030, I want to appeal for support to government in the fight against HIV”, he appealed.
The UNAIDS Executive Director, in a statement obtained from UNAIDS website, highlighted barriers to access healthcare for People Living with HIV/AIDS to include: gender inequality, racial inequality, social and economic inequalities, saying the world is altogether becoming an unequal world for global citizens. “We are becoming a more unequal world”.
Byanyima continued: “Our goal of ending the AIDS epidemic was already off track before COVID-19. We must put people first to get the AIDS response back on track. We must end the social injustices that put people at risk of contracting HIV. And we must fight for the right to health. There is no excuse for governments to not invest fully for universal access to health. Barriers such as up-front user fees that lock people out of health must come down”, she emphasised.
In winning the war against HIV/AIDS amidst COVID-19, she said “only global solidarity and shared responsibility will help us beat the coronavirus, end the AIDS epidemic and guarantee the right to health for all”.
Maura Quinlan, an assistant professor in the Department of Obstetrics and Gynaecology at the North-western University Feinberg School of Medicine has recently enlightened young female adults about vaginal discharge, saying there is no cause for alarm with the development.
She added that they should rather be worried if they don’t regularly have some vaginal secretions in their underwear, because it is mostly a sign that your vagina is staying healthy. “It’s like saliva in your mouth—it should be there”.
The findings reported in shethepeople says water discharge from the vagina or vaginal discharge is the fluid secreted by the glands in the vagina and cervix. The fluids flow out of the vaginal opening carrying out old cells that have lined the vagina. This is the body’s way of keeping the vagina clean, healthy, and lubricated.
Vaginal Discharge is Normal, it Shows You’re Healthy – Gynaecologists Explain
The colour and the amount of normal vaginal discharge vary from person to person. In the same vein, Dr Aakriti Gupta, a gynaecologist, told SheThePeople, “Basically the colour is transparent to white and there is no odour or smell.”
Jessica Shepherd, M.D., gynaecologic surgeon at Baylor University Medical Centre at Dallas, added that your discharge is a clue that your vagina is cleaning itself properly.
Shepherd also said that your vagina is a sensitive environment. It’s constantly working to stay lubricated, maintain its pH balance, and keep good vs bad bacteria in check.
“Self-cleansing through discharge is one of the things your vagina does to achieve these goals. That discharge usually comes from the vagina itself and mucus made by your cervix, the low, narrow portion of your uterus”, said Suzanne Fenske, M.D., assistant professor of obstetrics, gynaecology, and reproductive scientist at Mount Sinai Health System.
Dr Fenske said since discharge does such a stellar job of cleaning your vagina, you don’t need to do anything to help it out. That means no “special” products marketed towards making your vagina cleaner—things like douches can just upset your natural pH balance and promote irritation and infection.
Your discharge will usually fluctuate throughout the month—except if you’re on hormonal birth control containing oestrogen.
“Normal vaginal discharge can change in consistency and colour throughout your cycle,” Dr Fenske says.
There are various types of funky discharge changes that signal something is off with your vagina.
“You know what’s normal for you, and any major, lasting shifts in your discharge should be flagged for your doctor, even if they don’t seem particularly worrisome. But there are certain kinds of discharge that should prompt a call to your gynaecologist, because they probably mean your vaginal health is compromised.
“Yellow or green discharge: “That indicates that your body is trying to fight an infection,” Dr Shepherd says. Possible culprits include sexually transmitted infections like gonorrhoea, chlamydia, and trichomonas, a lesser-known STI caused by a parasite. Bacterial vaginosis, which happens when “bad” bacteria in your vagina (anaerobes) outnumber “good” bacteria there (lactobacilli), may also be the cause.
“These infections typically cause a foul-smelling vaginal odour, another sign you should ask your doctor for evaluation.
“An uptick in grey or white discharge: While yellow or green discharge is a sure sign something’s up, that doesn’t mean lighter discharge is always okay. All of the above infections can cause an uptick in grey or white discharge as well. This is why it’s important to tell your doctor if you’re seeing a lot more of the stuff, even if the colour doesn’t immediately seem off.
“Cottage cheese-like discharge: Having itchiness or burning with discharge that resembles cottage cheese can mean you have a yeast infection. But if you keep self-treating what seems like a yeast infection and it always comes back, see your doctor. You may have recurrent yeast infections (meaning you get four or more a year) that require longer treatment, or your “yeast infection” may be something else entirely, like chlamydia or gonorrhoea,” Dr Shepherd emphasized.
Bloody discharge not related to your period: If you’re seeing pink, red, or brown discharge at any point in your cycle other than during your period or just before it, you should call your doctor, Dr Quinlan says. You could just be spotting unexpectedly due to something like a change in your birth control or cervical polyps (non-cancerous growths on your cervix). However, in rare cases, bloody discharge can be a sign of cervical cancer, according to the Mayo Clinic.
As part of activities to commence the on-going Abuja 2020 ACPN National Conference, tagged “Unity 2020”, the Minister for Women Affairs and Social Development, Mrs Pauline Tallen, accompanied by National Chairman, ACPN, Pharm. Samuel Adekola; Immediate Past National Chairman, ACPN, Pharm. (Dr) Albert Kelong Alkali, joined hundreds of community pharmacists nationwide to walk against COVID-19.
The ACPN Walk against COVID-19, started at the International Conference Centre (ICC), venue of the conference and was conducted across major streets around the area.
Addressing the community pharmacists before the exercise, the Minister for Women Affairs and Social Development, Mrs Pauline Tallen congratulated the ACPN on its 39th Annual National Conference, and stated that the federal government was leaving nothing to chance, in its effort to win the war against COVID-19.
According to her, it is important to bear in mind that this phase, more than before is in the hands of the people, more than in the hand of government.
She therefore called on all, to take responsibility in ensuring that they actively play their roles to prevent further spike in COVID-19, as it has been observed in many countries, especially the foreign countries.
Minister for Women Affairs and Social Development, Mrs Pauline Tallen (middle) flanked by other dignitaries and community pharmacists before the commencement of the walk
“We must fight the spread of the disease by adhering more strictly than ever, to the various social guidelines which have been announced, published and publicised,” she advised.
On his part, the national chairman, ACPN urged Nigerians to wear their face mask in the public, once they leave their house, or even inside their house if they were not sure of the COVID-19 status of people they live with.
He added that community pharmacists, as key players in the healthcare team owe it as a responsibility to sensitise the public on major health challenges, adding that the ‘Walk’ was in fulfillment of that responsibility.
Adekola emphasised the roles of pharmacists in the management of diseases, stating that they are the primary custodians of medicines, and as such, they have the responsibility to create awareness and sensitive people in the society.
Pharm. Ade Popoola, managing director of Reals Pharmaceuticals, is a Fellow of the Pharmaceutical Society of Nigeria. A 1983 graduate of Pharmacy, he was formerly an area manager at Roche (Nigeria) Limited (1990-1992) before becoming sales and marketing manager at Jagal Pharma Limited (1992-1994) and then operations manager, also at Jagal Pharma (1994-1995), from where he resigned to set up Reals Pharmaceuticals.
In this exclusive interview with Pharmanews, Popoola reckons that the Pharmacy Tower project remains one of the best efforts to have ever come from the pharmacy family in Nigeria, adding that it would benefit the industry in no small measure. He also speaks on sundry issues relating to the pharmaceutical industry in Nigeria and advises young pharmacists to delay gratification while focusing on actualising their lofty dreams of excelling in their chosen paths. Excerpts:
What is the vision driving Reals Pharmaceuticals?
Our vision is to be a foremost pharmaceutical company with the most satisfied stakeholders, while not forgetting the fact that we want to make affordable products available to the populace.
Talking about the pharmacy industry in Nigeria, what would you say is the greatest challenge facing the industry?
Number one is low barrier to entry. Anyone that has five million plus can say he wants to start a pharmaceutical business. It has now become a decimated industry; we are fragmented and this has made products not to be profitable. It has resulted in low profitability.
There are so many people doing the same thing, and so, we are all trying to come out from the same door. When so many people are trying to come out from the same door, what you will get is chaos, leading to crash in prices.
Once you have too many registered brands of the same chemical entity, they will only compete on price and not on quality. They will all claim to have NAFDAC number. And so, most times, the profit that comes to us becomes very low because the low barrier to entry has caused everybody to be a player to the point that everyone that has a shop is both a player and an importer.
The issue of our porous ports is another challenge, as anybody can bring in anything. Retailers are importers; wholesalers are importers; distributors are importers. So, the trend has made the market to be unduly crowded. In the prevailing circumstance, it is only those who can distinguish themselves through marketing that can be outstanding.
Many pharmacists have bemoaned the unstable exchange rate in Nigeria as one of the factors militating against the pharmaceutical industry. Do you share such sentiment?
I share their pain. In fact, I will start with the non-availability of forex. It has to be available before we can even talk of exchange rate. It is not even available. Instability means that everyone is buying at fluctuating rates. But in my own case, it is non-availability.
Government is trying to do something to make forex available to those in the production of essential commodities, just like those of us in the pharmaceutical industry. Instability is a major challenge but non-availability is worse by my own reckoning.
What would you say is the experience of Reals Pharmaceuticals regarding the COVID-19 pandemic?
COVID-19 has had a positive impact on the pharmaceutical industry because, without drugs, we are all dead on arrival. It gave us the opportunity to bring our products to the forefront.
During that period, most hospitals closed down and could not operate. But for the pharmaceutical industry which made drugs available, the situation could have been more catastrophic.
COVID-19 helped our business to scale up a bit. However, we need to up our game and thank God that the Federal Government is making funds available to the industry through the health intervention fund under the auspices of the Central Bank of Nigeria.
High cost of funding (loan) is another huge challenge at up to 25 per cent interest. We must be able to sort this out. Thank God, the federal government has given us a single digit interest rate that would enable us improve our operations and make drugs available to the populace.
Do you manufacture your products locally or import them?
We are running a hybrid company. About 35 per cent of our products are locally manufactured while 65 per cent are imported. We manufacture through a third party and we are doing very well in that regard.
To what extent do you think the Pharmacy Tower project will benefit the pharmacy family in Nigeria?
Number one, it would benefit the pharmacy family financially because it will generate enough funds to enable us do the things we are supposed to do. Number two, the image of pharmacy will be enhanced. That land has been there for close to 40 years. For the project to be brought up, it is just like removing a reproach from the pharmacy family in Nigeria. Simply put, it will benefit us commercially and image-wise.
If other professions can have their own houses, Pharmacy, the oldest profession in Nigeria, should have its own. The tenure of Mazi Sam Ohuabunwa will be continually applauded and remembered because the response of people to the project has been awesome and very encouraging. As a member of the fundraising committee, I am highly impressed.
What is your candid advice for young and upcoming pharmacists?
They must understand that everything in life has time. They should also apply the principle of deferred gratification in whatsoever they are doing. This means that, if they can be patient and work hard, they will surely get to whatever height they are willing to get to in life.
It also implies that there is no short-cut to success in life. It is only God that can open a door, which no man can shut. When it is your time, God will open that door. You don’t need to struggle.
You must have heard about the story of the two Nigerian young men who created Paystack. Their initiative has been bought to the tune of 200 million dollars. It is only God that can open such a door. As it stands now, they are financially bigger than three Nigerian banks. It can only be God.
When you do what you know how best consistently, continuously and without cutting corners, you will surely get there. How many pharmaceutical companies in Nigeria are worth 200 million dollars? Once you are close to God, all things are possible. Don’t allow peer pressure to push you into thing you should not do. And remember not to compare yourself with others.
Towards reducing maternal mortality ratio and ensuring optimum health for women of reproductive age in the country, family health expert, Dr Folasade Oludara, has warned women against having unplanned pregnancies.
Oludara, who is the director of Family Health and Nutrition, Lagos State Ministry of Health, stressed the need for women to avail themselves of family planning options to manage their fertility to forestall the occurence of unintended pregnancies.
In the same vein, the World Health Organisation, (WHO) has asserted that about 214 million women of reproductive age in developing regions who want to avoid pregnancy are not using a modern contraceptive method.
The apex health institution, through its recent Fact Sheet on family planning disclosed that of the 1.9 billion women of reproductive age group (15-49 years) worldwide in 2019, 1.1 billion had a need for family planning. It added that while 842 million are using contraceptive methods, 270 million have an unmet need for contraception.
Speaking on the Post Pregnancy Family Planning Project (PPFP) platform recently, Oludara said “Women of reproductive age should realise that they are fertile and can prevent themselves from having unplanned pregnancies.
“We should not have babies by chance; rather consider the health of the mother and economic implications. You must have an intention to have a baby before you get pregnant.
“With life and family planning, people have time to focus on their health and wellbeing because they are not overwhelmed by unplanned pregnancies”.
She explained the essence of the PPFP project, saying it is to provide an opportunity to access family planning immediately after delivery, to avoid any worries about having unintended pregnancies that can endanger the health of the mother.
The family planning expert hinted on the different methods available for women at either public or private facilities, by trained providers. She listed these to include oral contraceptive pills, implants, injectables, patches, vaginal rings, intra uterine devices, condoms, male and female sterilisation, lactational amenorrhea methods, withdrawal and fertility awareness based methods.
Oludara also noted that the public sector in Nigeria plays a more prominent role than the private sector in the provision of modern contraceptive methods (54 per cent to 41 per cent), adding, however, that this role varies by method type.
“The public sector is the predominant source for IUDs (79 per cent), implants (93 per cent), and injectables (74 per cent). The private sector is the main source for male condoms (81 per cent), emergency contraception (80 per cent), and pills (67 per cent)”, she explained.
As a means of encouraging women to seek for the best method of family planning, Esther Adeola, a businesswoman, and a satisfied family user, said: “I was on family planning for four years. I got pregnant two weeks after removing the family planning method. And I have a friend also, she is on family planning, the same method. She didn’t add weight. She is still herself and she is doing good.
“If you plan your family, you will enjoy yourself, you will enjoy your family and you will be able to take care of yourself and your children.”
The menace of fake drugs in Nigeria reached its zenith around the year 2000, when it was estimated that fake drugs constituted more than 70 per cent of the drugs in the country. Many pharmaceutical businesses closed down, while most of the foreign ones moved out of the country because they were being suffocated by fake drugs imported mainly from India and China.
Consequently, Pharmanews which depended on the patronage of the industry was very adversely affected. We started owing the printers and staff salaries and I was considering closing down the business to try another occupation. It was during this period of uncertainty and depression that I took a cheap night bus to Abuja on 22 October, 2000, to see the then Minister of Health, Dr Tim Menakaya.
Pharm.(Sir) Ifeanyi Atueyi
On the morning of the next day, I went straight to the Ministry of Health Secretariat with a very heavily disturbed mind. While waiting to see the minister, I sat alone, in God’s presence, at the gardens outside, with some thoughts flooding my mind. Then I took my notebook and pen from my bag and started writing some prayer points, as they came to me. Below are some extracts:
“My Father, I put all my hope on you… Father, please send the people you have predestined to help me. I can no longer be in debt from today. On the Cross of Calvary, Jesus paid all my debts, took away my diseases, afflictions, poverty, lack, shame, and disgrace. I am set free from all these as a believer.
“Father, demonstrate your love, goodness and mercy on me now. Please answer my prayer. Let your purpose for my life be fulfilled. I surrender my thoughts, ambitions, plans and programmes to you… Your thoughts and plans for me are for good.
“Father, you have led me so far on this trip. Please crown it with glory. Make it a success… Holy Spirit, lead and direct me. Put words in my mouth to say the right things. Please go with me to see Dr Anabueze and the minister. Speak through me to get the desired result.
“I have taken a step of faith by coming here. I want my faith to work … Today, something new will happen to me. I will go back to Lagos glorifying You for your love, faithfulness, kindness and mercy.
“I have put in 20 years into Pharmanews and You have blessed me. I have made a name and, in later years, my Reflections have made significant impact on people. I have used it to evangelise. It is not God’s plan that I sink into debt and become a borrower instead of a lender. No! It is Satan’s plan and not God’s.
“The Word of God says that I will not borrow but instead lend to others. Satan comes with contrary ideas and lies…But God is omnipotent. He caused the children of Israel to pass through the Red Sea on dry land and caused Pharaoh and the Egyptian army to be swallowed by the Red Sea. God caused water to come out of the rock. He has raised the dead. Dry bones have been given flesh and the breath of life. God is the same yesterday, today and forever. He will perform His miracle in my life.
“I have put my life into Pharmanews and made significant contributions to the world of Pharmacy. I have become the best. Now, God, do you want me to try something else? You called out Abraham and asked him to go to a place you would show him. He obeyed. My Father, are you calling me out of Pharmanews? Is it your voice I am hearing?
“Holy Spirit, lead me to the right decision. Speak to me. I will listen attentively. Work out your programme for my life. Lift me out of this condition. Something is not going in the right direction and I reject this trend in Jesus’ name. Do not leave me alone mid-way so that I do not get lost. I cannot depend upon myself to succeed. I cannot do it with my carnal mind or worldly wisdom. Please take control of my plans and actions.”
Twenty years after the above supplications were made, I am glad to say that God graciously answered my prayers and arranged everything to work according to His own plans to fulfill His purpose for my life. The assumption of office by Prof. Dora Akunyili as the DG of NAFDAC in April, 2001, marked the beginning of some drastic steps to control the influx of fake drugs into the country.
Neurologist at the National Hospital, Abuja, Dr Yusuf Zubairu, on Sunday warned that inserting objects and forcing liquid into the mouth of an epileptic person during seizure does more harm than good.
Epilepsy is a disorder in which nerve cell activity in the brain is disturbed, causing seizures, which makes a person experience abnormal behaviour, symptoms and sensations, sometimes including loss of consciousness.
Zubairu, in an interview with the News Agency of Nigeria (NAN) in Abuja, said 70 per cent cases of epilepsy are unknown, while other factors such as genetic disorder or an acquired brain injury, such as a trauma or stroke, may result to it.
“Other known causes include brain infections like meningitis, cysticercosis, stroke, brain tumour, head injuries like birth injuries and accident in adults.
“Also, infection during pregnancy that affect the brains of babies, low oxygen in babies during birth and genetic conditions that result in brain injury are some of other causes of the neurological disorder,” he said.
The neurologist, therefore, advised the public to be calm, remove harmful objects, loosen tight neckwear for persons experiencing seizures.
“If a person has fallen, turn to the side and put something soft under the head.
“Never put anything in the mouth or pour water and anointing oil, but observe closely so you can provide detailed information to medical personnel,” he said.
He said certain efforts should be in place to reduce the risk of head injuries, stroke, seek antenatal care,stay healthy during pregnancy as well as practice safe delivery. “Reduce risk of head injuries like using seat belts for adults and children, motorcycle helmets. Treat head injuries early.
“Reduce the risk of stroke by eating well, exercising, not smoking and treating hypertension.
“Seek antenatal care, stay healthy during pregnancy and practice safe delivery,” he said.
He further advised that persons who have incidences of epilepsy should seek medical attention, take their medication regularly, avoid triggers like stress, alcohol, sleep deprivation, hunger, flashes of light, caffeine and others.
The expert, therefore, called on the government to create more public enlightenment on epilepsy to dispel fear, discrimination and social stigmatisation.
“Epilepsy is not contagious and it is treatable. Anyone can be epileptic. It’s not their fault that they are. It is not a spiritual attack either,” he said.
According to the World Health Organisation (WHO), around 50 million people worldwide have epilepsy and an estimate of five million people are diagnosed with epilepsy each year.
L-R: Pharm. Olateju Olakiigbe, managing director, Egbeda Pharmacy, speaking at the occasion, with Pharm. Olabanji Benedict Obideyi, chairman, Lagos ACPN at the commissioning.
It was harvest of encomiums for the management of the Pharmaton 693, a cooperative society formed by a group of pharmacists with the aim of advancing individual’s economic growth with pooled resources; following the society’s procurement and official opening of it’s ultra-modern wholesale pharmacy outlet in Egbeda, Lagos State.
The official commissioning of the Pharmaton Cooperative Wholesale Pharmacy, which took place at the company’s head office in Idimu, Lagos on 25 November 2020, had a large turnout of pharma personalities as well as members of the public.
Speaking at the occasion, Pharm. Olateju Olakiigbe, managing director, Egbeda Pharmacy, Egbeda Lagos, who was the chairman of the occasion, commended the leadership of the society for sustaining the group in spite of challenges that faced it.
Pix Pharm. Olateju Olakiigbe, managing director, Egbeda Pharmacy, cutting the tape to commission the new Pharmaton Cooperative Wholesale Pharmacy, Egbeda, with other dignitaries.
The respected elder of the pharmacy profession while applauding the founding fathers of the Pharmaton Cooperative Society for conceiving such a big vision, however noted that he was highly impressed with the level of discipline, tenacity of purpose displayed so far by the leadership in the last 27 years.
“I must commend the outgoing and the past leadership of the society for this vision, and I would like to encourage those at the helms of affairs today not to lose focus and not to let the standard down. I encourage you not to let your guard down, dream new dreams, and continue working with sincerity of purpose, so that the labour of the past leaders will not be in vain,” he advised.
While speaking, Pharm.Iyiola Gbolagade, chairman, PSN, Lagos State, who was represented by the vice-chairman, Pharm. Babayemi Oyekunle, expressed his joy that some pharmacists 27 years ago could come together and run a viable cooperative society, noting that if other pharmacists could copy the same model, most of the challenges facing the practice of pharmacy in Nigeria would have been resolved.
Pharm. Olabanji Benedict Obideyi, chairman, Association of Community Pharmacists of Nigeria (ACPN), Lagos State chapter, also shared same view with Gbolagade when he said members of Pharmaton 693 should sustain the ideals that had been guiding them since inception, adding that Pharmacy practice has changed significantly necessitating thinking out of the box and doing things differently.
Speaking on the newly commissioned Pharmaton Cooperative wholesale pharmacy, Obideyi, noted that there is need for more credible wholesalers around to be able to service the need of the retailers to reduce or stamp out patronage of the unofficial or unapproved drug markets.
He added, “I want to congratulate Pharmaton 693 Cooperative and advise that more funds be pumped into the pharmacy to enable it increase its stocking level and geared towards making it a pharmaceutical hob where virtually all the drug needs of retail community pharmacies would be met”.
In his welcome address, the outgoing President of the society, Pharm. Olusola Jaiyeoba, noted that the society which started with few disciplined and determined individuals who were goal getters has steadily become a enviable group today, adding that the society attained its enviable status due to the discipline and commitment of its members.
According to Jaiyeoba, who had served as the president for two years before coming back to serve for another four years, the society had undergone tremendous transformation and had weathered several storms. He added that together as a team, the society had attained the enviable position of being one the best managed community-based cooperative societies in Lagos State and had graduated from a thrift society to a Cooperative Multipurpose Society Limited (CMSL).
He added that the society transmuted to a multipurpose society in order to widen its operational base and diversify into hitherto untapped areas like asset acquisition, property development and other high interest yielding ventures.
Also speaking, a one-time president of the society, Pharm. Gafar Madehin, disclosed that Pharmaton cooperative was instituted in June, 1993, because the founding fathers believed that when resources are pooled together, there is tendency to achieve more and bigger goals, adding that the society derived its name Pharmaton 693, from the date it was established.
In appreciation of the felicitations and goodwill messages, Pharm. Kehinde David Oluwafemi reiterated the fact that Pharmamaton Cooperative Wholesale Pharmacy is solely into wholesale distribution and has no intention of competing with the same retail outlets she ought to service in the area, adding he is ready to improve on the successes recorded by the outgoing president and other past leaders of the society.
“In the past, we have had very strong presidents and they have laid solid foundation, especially the last two, Pharm. Gafar Madehin and Pharm. Olusola Jaiyeoba, under whose the society mutated into CMSL, so it is my hope to build on their achievements and by God grace, I have it as a goal to have at least five retail pharmacies and to modernize this business before leaving office.
The expansive new outlet was declared open by the Chairman of the occasion and managing director, Egbeda Pharmacy, Pharm. Olateju Olakiigbe.
Also present at the ceremony were officials of the Alimosho Local Government Cooperative Society; Zonal ACPN Chairmen, Representatives from ECOBANK, Pharm. Clement Ogunleye of Teta Pharmaceuticals Limited; Members of the Lagos State Neighborhood Safety Corps and others.
The country has five years to the target set by Nigeria for ending open defecation nationwide
Only 22 more local government areas in Nigeria have become open defecation free (ODF) since last year, the Minister of Water Resources, Suleiman Adamu, says.
This brings to 38 the number of LGAs which have attained the status, five years to the target set by Nigeria for ending open defecation nationwide.
The minister said this at the first anniversary of the “Clean Nigeria: Use the Toilet Campaign” in Abuja on Thursday.
Man seen defecating in an open place
He said the 22 local government areas became open defecation free (ODF) after the government started the campaign in 2019 to end open defecation.
“Over this one year period of the campaign, the number of ODF LGAs in the country has increased from 16 in 2019 to 38 as at November.
“Additional six LGAs are in the process of being validated as ODF by the National Task Group on Sanitation,” Mr Adamu said.
He said the ministry was able to achieve the feat despite limitations of the COVID-19 pandemic and commended all partners for their contributions to the achievement.
“In recognition of their commitment, the ODF LGAS will be prioritised for water supply interventions under the Partnership for Expanded Water, Sanitation and Hygiene (PEWASH) in accordance with the established programme protocol,’’ Mr Adamu said.
He frowned at some states which were still not showing any appreciable progress or action in addressing Water Sanitation and Hygiene (WASH) issues especially towards ending open defecation.
“ We recognise that the success of this campaign is dependent on strong engagement with states, LGAs and other stakeholders to secure the needed political and high-level commitment required to drive the campaign,” Mr Adamu said.
The minister gave assurance of the ministry’s commitment to building more partnerships and collaborations within and across sectors to ensure that deliberate and sustained attention needed to end open defecation in the country was in place.
He expressed optimism that the event would motivate states lagging behind to strive towards achieving the intended objectives of the Clean Nigeria Campaign.
Mr Adamu said this would result in a healthy competition that would drive the nation towards ending open defecation by 2025.
On his part, the Minister of Environment, Mahmood Abubakar, urged Nigerians to partner with stakeholders on ending open defecation, stressing that open defecation was detrimental to human well-being.
The Organised Private Sector in Water, Sanitation and Hygiene (OPS-WASH) representative, Nicholas Igwe, commended the Ministry of Water Resources for the support in the fight against open defecation as well as the launch of OPS-WASH Project“ Flushit’’ at the anniversary celebration.
Vice President Yemi Osinbajo commended the Ministry of Water Resources for complying with the Executive Order on ODF and urged that efforts to end open defecation be put into effect by 2025.
Mr Osinbajo advised that all public places such as markets, offices and worship centres must have accessible toilets within their premises to end open defecation.
The doctors plan to go on strike because the government is not giving them medical insurance.
Kenyan doctors are threatening to go on strike next month unless the government addresses their concerns about safety, health insurance, and staffing needs to fight COVID-19. The threat comes after at least 10 doctors died from the virus this month.
Speaking to reporters in Nairobi Tuesday, the secretary-general of the Kenya Medical Practitioners and Dentists Union, Chibanzi Mwachonda, said his members plan to go on strike because the government is not giving them medical insurance.
“If these doctors are not covered, then this strike will kick off until the time that they will be covered,” Mwachonda said.
Ondo Doctors Protest Four-Month Unpaid Salaries
Kenya has lost 32 medical workers to COVID-19, at least 10 of them in the last two weeks. The deaths have angered medical workers.
Watende Andrew lost his younger brother to the disease. His late brother, a doctor, worked at the University of Nairobi. After seven days in the hospital, he died.
“I think because of other comorbidities he was in the category of severe disease, he got the best attention he could but I think still because of comorbidities he developed hypoxia with saturation which were low. Then when they were trying to intubate he passed on,” Andrew said.
Doctors also complain about not receiving adequate personal protective gear. The union says all their requests are met with silence.
Recently, President Uhuru Kenyatta opened a new health facility with 100 beds for United Nations staffers and the diplomatic community.
Meanwhile, some Kenyans say they were turned away at health facilities and advised to take care of themselves at home.
Mwachonda is calling on the government to employ at least 2,350 doctors and medical workers to attend to the sick in various hospitals across the country.
“There is an acute shortage of doctors in this country in each and every county and our demand that each county must employ at least 50 doctors to cover for COVID and for the other services. If this is not addressed equally, we shall be on strike come on the 6th of December,” Mwachonda said.
The Kenya Nurses Union has also issued a 14-day strike notice. The union is demanding compensation for the families of 18 nurses who died from COVID-19 and salaries for some nurses, who have not been paid for months.
The head of the National Assembly Health Committee, Sabina Chege, said Kenya cannot afford to see doctors not working during this challenging period.
“It’s not a unique situation where doctors are feeling that they are not taken care of by the government. At what point do you say it’s optimal or enough? It can never be enough but people can try, and we can’t manage everything. Let’s look at what is the priority, what can we be able to do for now, what can wait for a month or two then we can have an agreement. I don’t think the strike will solve anything. We’ll lose more life and nobody is safe,” Chege said.
Kenya has recorded 77,800 coronavirus cases and 1,400 deaths since March.
A parliamentary committee will meet Wednesday with county governors and other officials to discuss ways to avert the strike.
The head of British drug manufacturer AstraZeneca said on Thursday further research was needed on its Covid-19 vaccine after questions emerged over the protection it offers, but the additional testing is unlikely to affect regulatory approval in Europe.
AstraZeneca and its partner, the University of Oxford, announced on Monday that it was seeking regulatory approval for the vaccine after it showed an average 70-percent effectiveness.
That rate jumped to 90 percent when an initial half-dose then a full dose was given, similar to that in rival vaccines in development by Pfizer/BioNTech and Moderna.
But US scientists have said the higher rate of effectiveness came during tests in people aged 55 and under, and was discovered by accident during the clinical trials.
The head of the Oxford Vaccine Group, Andrew Pollard, said this week that further evidence will be available next month, but the result was still “highly significant”.
“Now that we’ve found what looks like a better efficacy, we have to validate this, so we need to do an additional study,” AstraZeneca chief executive Pascal Soriot told Bloomberg.
He said he expected that to be another “international study but this one could be faster because we know the efficacy is high, so we need a smaller number of patients”.
The additional trial was not likely to delay regulatory approval in Britain and the European Union, Soriot said.
There are high hopes for the AstraZeneca/Oxford vaccine, which Pollard has hailed as a “vaccine for the world” given that it could be cheaper to make, and easier to store and distribute.
It can be stored, transported and handled at normal refrigerated conditions of between two and eight degrees Celsius (36-46 Fahrenheit) for at least six months.
Pfizer/BioNTech’s offering requires temperatures of -70C, driving up costs and potentially making it out of reach for lower and middle-income countries.
AstraZeneca/Oxford has also promised to provide its vaccine to the developing world on a non-profit basis.
– Wait and see – The World Health Organization said it looked forward to the full publication of the data from the trial.
“On a review of the detailed data, we will be better positioned to understand the vaccine performance,” it said.
The chief medical officer for England, Chris Whitty, also cautioned against drawing premature conclusions, and urged patience until the data were published in peer-reviewed journals.
“It’s always a mistake to make too many judgments early and in particular before the independent regulator has had a chance to look at the results,” he told a news conference.
Helen Fletcher, professor of immunology at the London School of Hygiene and Tropical Medicine, said the safety data available on the vaccine had been “very robust”.
“It’s possible that a lower initial vaccine dose could result in higher vaccine efficacy… More is not necessarily better when it comes to vaccines and immunotherapies,” she said.
“It’s also possible that a strong immune response to the first vaccine could effectively block an immune response to the second shot of the same virus.”
Fletcher’s colleague, professor of pharmacoepidemiology Stephen Evans, said speculation about the age distribution in the trials was “not useful to anyone”.
“We have good grounds for trusting that the regulation in this high-profile area will be done as carefully or more carefully for these vaccines than for any others in the past,” he said.
Gillies O’Bryan-Tear, from the UK Faculty of Pharmaceutical Medicine, said “the eventual efficacy rate may change”, but “the validity of the low dose/high dose group results are unlikely to be questioned”.
“Even if they (the regulators) decided to ignore the results of the low dose/high dose group, the study of the high dose/high dose patients will still be strongly significant, but I think that it unlikely,” he said.
-As St. Racheal’s Pharma commemorates World Antimicrobial Awareness Week 2020
L-R: Pharm.(Mrs) Adeola Alli, co-founder/CEO OneHealth Pharmacy; Pharm. Akinjide Adeosun, chairman/CEO, St. Racheal’s Pharmaceuticals; Dr Tomi Coker, commissioner for health, Ogun State & Dr Mutiu Bamidele, consultant medical microbiologist,LASUTH during the media event commemorating the 2020 World Antimicrobial Awareness Week (WAAW) in Lagos.
To avert a colossal loss of lives to the tune of ten million by the year 2050 across the globe, with developing countries having higher prevalence of antimicrobial resistance (AMR), stakeholders have urged governments at all levels to step up its implementation of health policies in the country, while stiffer punishment are mete out to violators of established regulations.
The seasoned healthcare practitioners, who converged at the head office of St. Racheal’s Pharmaceuticals, in Lekki Penisula, Lagos, engaged in four hours conversation on the eradication of AMR include Commissioner for Health, Ogun State, Dr (Mrs) Tomi Coker; Chairman/CEO, St. Racheal’s Pharmaceuticals Pharm. Akinjide Adeosun; Consultant Medical Microbiologist, LASUTH, Dr Mutiu Bamidele; Pharm.(Mrs)Adeola Alli, co-founder/CEO OneHealth Pharmacy; Dr Olufunke Adeyeye; LASUCOM; and others.
They unanimously agreed that the prevalence of AMR is extremely high in Nigeria, while government and all stakeholders need to up their games in preventing the condition from degenerating into a crisis.
Some of the factors fueling AMR in the country as identified by the experts are poverty; use, misuse and overuse of antibiotics in humans, animals and plants; lack of access to clean water, sanitation and hygiene; inadequate infection prevention and control; non-implementation of healthcare policies; among others.
Speaking on the theme of the World Antimicrobial Awareness Week 2020, “United to preserve antimicrobials”, the Ogun State Commissioner for Health stressed the need for more awareness creation on the part of practitioners, noting that there is huge ignorance about antibiotics usage among the populace which explains reason for the high prevalence of AMR.
She also called on regulatory agencies like PCN and NAFDAC to be more thorough in their monitoring activities, as defaulters of regulations are to be severely punished, to serve as deterrent to others.
“We have a million and one policies and researchers have discovered that our policies in Nigeria are parts of the best policies worldwide, unfortunately, we are not implementing them. Locally there are policies that support the domestication of the global action plan such as the NCDC antimicrobial use and resistance in Nigeria published in September 2017. Concurrently, the Federal Ministry of Health, Agriculture and Environment published the situation analysis on antimicrobial use and resistant in Nigeria. So all these are out for us, but what are we doing with them?
“Pharmacists, microbiologists and doctors should commence advocacy visit to policy makers at the national and sub-national levels to challenge them on actions on existing AMR policy, because if we are not careful, this might become a crisis, maybe another pandemic, because if it is not controlled, it will get out of control”, she warned.
On his part, the St. Racheal’s boss, Pharm. Adeosun tasked government on alleviating poverty among the citizens saying about 40 per cent of the Nigerian people live below its poverty line, which is N137,430 a year, or N11,452 in a month or N381.75 per day, as cited from the National Bureau of Statistics report about poverty and inequality in Nigeria from September 2018 to October 2019.
Adeosun who stated that a full dose of his company’s brand of antibiotics goes for about N1000, argued that it is impossible for the man on the street who spends N381.75 per day on food and non-food items to afford the cost of a full dose antibiotics. He thus laid it bare why it is easier for majority of the poor to purchase substandard antibiotics at cheaper rates than to patronise quality medicines. He said if poverty is not addressed, it is doubtful, if AMR can be controlled in the country.
“I believe to tackle the problem of antibiotic resistance, we need to tackle poverty (The Patients) & Funding (The Healthcare Industry). A patient who spends N381.75 per day on Food & nonfood cannot afford to buy a full dose of an antibiotic worth N1, 000.00. I urge our national & subnational governments to institute free medical care for the poor people.1% of the profit of companies should be legislated to fund this scheme at the national level & 1% tax from contractors at the sub national government. For it to be sustainable, I call on governments to make provision for free medical care in the annual budget”, he submitted.
Earlier, the Consultant Microbiologist, Dr Bamidele had defined AMR as a condition that occurs when bacteria, viruses, fungi, and parasites resist the effects of medications, making common infections harder to treat and increasing the risk of disease spread, severe illness and death.
Although he noted that multiple factors are responsible for the condition, but he mentioned a few of them which are overuse of medicines in humans, livestock, and agriculture, as well as poor access to clean water, sanitation and hygiene, adding that all these have accelerated the threat of antimicrobial resistance worldwide.
He explained further on the role of physician in antimicrobial stewardship, saying it involves the optimal selection, dose and duration of an antibiotic resulting in the cure or prevention of infection with minimal unintended consequences to the patient including emergence of resistance, adverse drug events, and cost. The ultimate goal is improved patient care and healthcare outcomes.
Dr Onyema Ogbuagu, has made Nigeria proud with his unique role in the development of the Pfizer’s COVID-19 vaccine, as the leading scientist in the trial.
Pfizer Inc had announced the successful completion of the vaccine trial which has shown 95% effectiveness in preventing the dreaded respiratory infectious disease.
Ogbuagu, a Nigerian-born medical doctor leading the Pfizer trial for the Coronavirus vaccine in the United States has been highly commended by other scientists in the country.
Applauding his innovation in discovering an effective vaccine for COVID-19, Director General of the Nigeria Centre for Disease Control (NCDC), Dr Chikwe Ihekweazu, and the Nigerian Medical Association (NMA) commended Dr Ogbuagu on his milestone feat.
“We are very proud of the efforts by Dr Ogbuagu and several other Nigerian scientists and health professionals in Nigeria and the diaspora, especially as part of efforts to end the acute phase of this COVID-19 pandemic,” Ihekweazu said.
“Despite the challenges in our country, there are several Nigerians that have been well-trained through our educational system and are in turn, contributing to scientific knowledge and interventions globally.
“At NCDC, we have received strong support from some of these health professionals in the diaspora through groups like Association of Nigerian Physicians in the Americas (ANPA), Nigerian Association of Pharmacists & Pharmaceutical Scientists in the Americas among others” he stated.
The Nigerian Medical Association (NMA) also joined in hailing the Nigerian-born researcher, Dr Ogbuagbu, for the achievement.
President, NMA, Prof. Innocent Ujah, says it is an encouragement to invest in the training of more doctors. “It shows they are committed. It shows they are focused. But unfortunately, they are not valued here. This is why many Nigerian doctors are travelling out of the country,” he said.
“The achievement is not just for the NMA but his family, the Federal Government of Nigeria and Africa. The government should recognise that the young man has made the country proud”, he emphasised.
An Associate Professor of Medicine and infectious disease specialist at Yale School of Medicine, Ogbuagu is also director of the HIV Clinical Trials programme of the Yale AIDS Programme, Section of Infectious Diseases of the Yale School of Medicine, New Haven, New York City.
He is one of the twin sons of Prof. Chibuzo Ogbuagu (former VC of ABSU and Abia SSG), whose parents had in New Haven CT, when they went for their doctoral programmes at Yale.
He was the Yale principal investigator on multiple investigational therapeutic and preventative clinical trials for COVID-19, including remdesivir (now FDA approved), leronlimab and remdesivir and tocilizumab combination therapy as well as the Pfizer/BioNTech Vaccine trial.
Ogbuagu’s responsibilities at Yale include educating and training medical students, residents and infectious diseases fellows in various capacities in inpatient and outpatient settings; and through structured course work and other teaching sessions.
Nearly a year after a mysterious pneumonia emerged in China and began its global spread, there is still no silver bullet treatment for Covid-19 despite an unprecedented effort to discover new medicines or repurpose existing drugs.
A single family of cheap, widely available medications — corticosteroids — has proven its effectiveness, but some other drugs that were initially hyped have disappointed.
What works? -Dexamethasone
This is the only treatment that has reduced mortality from Covid-19, although it has only been shown to work for patients who are severely ill in hospital and need oxygen therapy.
The World Health Organization (WHO), as well as the European Medicines Agency (EMA) have been recommending dexamethasone for these patients since September, based on the findings of a large British clinical trial called Recovery.
Dexamethasone can actually inhibit the immune system, so it should not be given to those in the early stage of the disease.
But this is why it works in those who are very ill — it acts to tame a runaway immune response, which can trigger the inflammation characteristically seen in severe forms of disease.
CoronavirusAVIRUS
And it appears that it’s not just dexamethasone.
Research published in early September in the American medical journal Jama showed that other drugs in the same corticosteroid family could also be effective, reducing mortality by 21 percent after 28 days for patients with severe Covid-19.
This led the WHO to recommend “systematic” use of corticosteroids in severe and critical patients.
Anticoagulants
Like corticosteroids, these drugs are used only in the most severely ill patients. The goal is to prevent blood clots, one of the serious complications of Covid-19.
What doesn’t work well enough -Remdesivir
For a time this antiviral treatment had the hopes of the world riding on it.
The drug, developed for Ebola, was initially thought to be very promising.
The European Commission announced that it had ordered 500,000 doses in October, while the US granted it permanent authorization for use.
Its manufacturer, US pharma giant Gilead, has said the drug boosted 2020 third quarter sales by almost $900 million (756 million euros).
But it has not lived up to expectations.
On November 20, the WHO said remdesivir should not be used to treat Covid-19 patients no matter how serious their illness, saying it had “no important effect” on survival chances.
That does not mean it is proved to be ineffective, but rather that it had not been shown to improve patient outcomes.
There were also concerns about possible side effects, particularly affecting the kidneys, as well as the drug’s cost.
The WHO advice was based on four international randomised clinical trials involving more than 7,000 patients hospitalised with Covid-19.
What does not work at all -Hydroxychloroquine
This drug became a lightning rod for politicised debates over the pandemic.
Used as a treatment for malaria or autoimmune diseases, depending on the country, hydroxychloroquine was touted as something of a miracle cure by its proponents — notably US President Donald Trump — despite a lack of evidence that it worked.
Among scientists, controversial French professor Didier Raoult argued vociferously in favour of the drug.
Hydroxychloroquine was at the centre of an academic scandal, when the prestigious medical journal the Lancet had to retract a study that suggested negative effects from the drug, after concerns were raised about the underlying data.
The retraction of research critical of hydroxychloroquine only served to galvanise supporters of the drug.
But study after study has shown that it is not effective against Covid-19 including the British trial Recovery, whose results were published in the New England Journal of Medicine in October.
Lopinavir-ritonavir
Used against HIV, the virus that causes AIDS, this one-two antiviral punch has shown to be ineffective at treating Covid-19 in hospital settings, according to the Recovery trial, which published its results in the Lancet in October.
Still under investigation -Tocilizumab
Scientists hope this immunosuppressant, currently used against rheumatoid arthritis, will be able to prevent potentially deadly inflammation in serious cases.
So far, however, studies have not yet provided a definitive answer.
Researchers from Imperial College London announced on November 19 that tocilizumab appeared to be having a beneficial effect, according to preliminary results from their clinical trial.
The larger-scale Recovery trial may reveal more in the coming weeks.
Synthetic antibodies
When the body fights off viruses such as SARS-CoV-2 it develops antibodies — proteins that are programmed to target specific pathogens.
These antibodies can be synthesised in a lab and could in theory be given to patients sick with Covid-19 to boost their own natural immune response.
Trump received this still experimental treatment, manufactured by the American biotechnology company Regeneron, when he was hospitalised with the virus.
This treatment, and one of the same type manufactured by Eli Lilly, have received authorization for emergency use in the US.
But their effectiveness continues to be evaluated, with the Regeneron treatment included in the Recovery trial.
Plasma
Plasma taken from the blood of recovered patients showed some early promise when given intravenously to people sick with Covid-19.
It has already shown to help speed recovery from Ebola as well as SARS, which is caused by the same family of pathogens as the novel coronavirus.
Recovery has an ongoing clinical trial for plasma treatment.
Fibroids can develop at any time during a woman’s childbearing years, the gynaecologist said
A Lagos-based gynaecologist, Wale Farayola, says heavy menstruation is one of the major complaints in people with fibroid.
Mr Farayola told the News Agency of Nigeria (NAN) in Lagos on Monday that fibroids are non-cancerous growths made of smooth muscle cells and fibrous connective tissue in the uterus.
According to him, fibroids can develop at any time during a woman’s childbearing years.
“Heavy menstruation or bleeding with or without pain is one of the major presenting complaints in people with fibroids.
Image of fibroid
“Some may have their menstruation extending beyond the normal time of three to seven days.
“Symptoms include menstrual disturbance (irregular bleeding), menstrual pattern may become irregular and the bleeding might be heavy in the presence of fibroid polyp or when a submucous fibroid become ulcerated.
“A large mass of fibroid may compress the surrounding organs and present corresponding symptoms like frequent urination or retention of urine.
“Fibroids may also cause mechanical distortion of the fallopian tubes which may cause infertility,’’ he said.
The gynaecologist said that no treatment was required if a fibroid had no symptoms.
“However, fibroids that enlarge the uterus to about the size of a 12-weeks pregnancy, whether with symptoms or not, should preferably be removed.
“Treatment could be medical or surgical. Medical treatment is the method of ovarian suppression using a gonadotrophin-releasing hormone analogue.
“These suppress circulating estradiol and progesterone levels by shutting down the pituitary-ovarian axis.“Unfortunately, while very effective in shrinking fibroids when ovarian function returns, the fibroids regrow to their previous dimensions.
“Also long-term use results in significant bone loss,’’ the gynaecologist said.
Mr Farayola said that some surgical treatments for fibroid include polypectomy, vaginal hysterectomy, vaginal myomectomy, abdominal hysterectomy and abdominal myomectomy.
He said that the recurrence rate of fibroids is extremely low, especially with newer operative techniques.
The Joint United Nations Programme on HIV/AIDS (UNAIDS) said on Tuesday that over 45,000 people living with the Human Immunodeficiency Virus (HIV) died last year.
Immunisation Team Lead for WHO Nigeria, Dr Fiona Braka and a representative of the UN agency, disclosed this at a press conference ahead of the 2020 World AIDS Day organised by the National Agency for the Control of AIDS (NACA).
Nigeria Lost Over 45,000 Persons to HIV in 2019- UNAIDS Reveals
She said the death is really unacceptable and this whole thing is happening during the period where government, donors and partners have successfully made life-saving medication and commodities available.
The World AIDS Day is celebrated December 1 every year to honour the people who have fallen to the disease as well as people living with HIV.
It is also celebrated to raise awareness of the disease and the need for people to know their status.
The theme for this year’s World AIDS Day is ‘Global Solidarity, Shared Responsibility’.
Ms Braka said the COVID-19 pandemic is threatening the progress that the world has made in health and development.
She also revealed that international agencies have gathered information from countries through an online platform to identify how the pandemic has affected the delivery of routine HIV services and emerging challenges.
Braka appreciated the country’s effort in achieving 73 per cent coverage concerning people knowing their HIV status despite challenges posed by the pandemic.
She, however, said more work needs to be done to get more people tested to know their status.
Director General of NACA, Gambo Aliyu, said Nigeria has adopted the theme, ‘United to End AIDS in the Midst of COVID-19, So Get Tested’ due to the pandemic ravaging the world.
“We have heard and seen the impact of it on HIV programs. Even though we are scrutinising our data to find out the real impact on people living with HIV and AIDS.
“One thing that we know without looking at our data, we know that in terms of very economic realities, COVID-19 has had an adverse economic impact compared to other outbreak population,” he said.
He noted that the agency has launched a project, Prevent, Protect and Empower in conjunction with the Federal Ministry of Women Affairs and Social Development and supported by UNAIDS.
He said himself and his team are focusing more on women simply because in terms of equality because when it comes to businesses and empowerment, women are mostly disadvantaged.
Lagos, Nigeria: Lifestores Healthcare pre-launches OGApharmacy, an online B2B pharmaceutical marketplace dedicated to making quality primary healthcare affordable & accessible to all, regardless of economic status. OGApharmacy currently serves over 70 affiliate pharmacies and approx. 200,000 end patients.
The marketplace, powered by Lifestores’ proprietary PharmIQ digital platform, offers group purchasing savings, loans, point-of-sales software and other digital health services.
“We started Lifestores to make quality healthcare the norm for all. At Lifestores, we see community pharmacies as the first port of call for primary healthcare, and work hand-in-hand with pharmacists to deliver health programs that serve all Nigerians. OGApharmacy is an opportunity to partner with trusted manufacturers and distributors, and pass on their discounts to pharmacies”, said Bryan Mezue, one of Lifestores’ co-founders.
OGApharmacy will be pre-launched in a virtual event on Zoom, 26th November, 2020. The pre-launch will be attended by key leaders from the Pharmaceutical Society of Nigeria (PSN) and the Association of Community Pharmacists of Nigeria (ACPN). ACPN has lent their support to Lifestores Healthcare with the aim of propagating OGApharmacy in community pharmacies in Lagos State.
“OGApharmacy is a pro-community pharmacy digital organization, offering the ‘BIG 4’ to help sustain growth in retail pharmacy space”, says Pharmacist Chinyere Chima, Senior Medical Advisor for OGApharmacy. “The retail business management software PharmIQ, Online Procurement platform, Soft Loan and access to Telemedicine are long over due to help community pharmacists in Nigeria”, she added.
About Lifestores Healthcare: Founded in 2017, Lifestores Healthcare is on a mission to democratize access to quality and affordable primary care by transforming pharmacies across Africa.
The novel coronavirus has killed at least 1,410,829 people since the outbreak emerged in China last December, according to a tally from official sources compiled by AFP at 11:00 GMT on Wednesday.
At least 59,794,270 cases of COVID-19 have been registered. Of these, at least 38,047,700 are now considered recovered.
The tallies, using data collected by AFP from national authorities and information from the World Health Organisation, probably reflect only a fraction of the actual number of infections.
Many countries are testing only symptomatic or the most serious cases.
On Tuesday, 12,699 new deaths and 596,028 new cases were recorded worldwide. Based on the latest reports, the countries with the highest figures for new deaths were the United States with 2,081 new deaths, followed by France with 1,005 and Italy with 853.
The United States is the worst-affected country with 259,976 deaths from 12,597,506 cases. At least 4,696,664 people have been declared recovered.
After the US, the hardest-hit countries are Brazil with 170,115 deaths from 6,118,708 cases, India with 134,699 deaths from 9,222,216 cases, Mexico with 102,739 deaths from 1,060,152 cases, and the United Kingdom with 55,838 deaths from 1,538,794 cases.
The country with the highest number of deaths compared to its population is Belgium with 138 fatalities per 100,000 inhabitants, followed by Peru with 108, Spain 93, Italy 85.
China – excluding Hong Kong and Macau — has to date declared 86,469 cases, including 4,634 deaths and 81,530 recoveries.
Latin America and the Caribbean overall has 438,067 deaths from 12,588,507 cases, Europe 384,397 deaths from 16,913,581 infections, and the United States and Canada 271,568 deaths from 12,937,677 cases.
Asia has reported 190,015 deaths from 12,045,126 cases, the Middle East 75,534 deaths from 3,185,933 cases, Africa 50,307 deaths from 2,093,240 cases, and Oceania 941 deaths from 30,210 cases.
As a result of corrections by national authorities or late publication of data, the figures updated over the past 24 hours may not correspond exactly to the previous day’s tallies.
A Non-Governmental Organisation, Bensther Development Foundation, says that infectious diseases are rampant among drug addicts in the society.
Executive Director of the foundation, Mr. Nonso Maduka, disclosed this during a Stakeholders’ Forum on Infectious Diseases, Drug use and Achieving SDG 3 on Tuesday in Enugu.
Maduka explained that infectious diseases such as HIV, tuberculosis, hepatitis C and B were prevalence among drug addicts, who inject the substance into their blood. He further asserted that one out of three persons who used cannabis had a mental health problem.
He noted that not all drug addicts were criminals as different reasons made them drug addicts.
Maduka urged the public to always discourage illicit drug users from using drugs, through counselling, showing them kindness, and taking them to hospital for treatment.
“There is a lack of facilities and capacity at the community health centres and substance abuse is community-based.
“Even among the health professionals, they cannot help a drug addict, rather they often scold or maltreat such a person,” he alleged.
Maduka said that treatment of drug addicts could be by rehabilitation, counselling, providing vocational education, through community development, among others.
Also speaking at the event, a Consultant Psychiatrist at the Federal Neuropsychiatric Hospital, Enugu Dr. Justus Onu, said that drug addicts required treatment because it is a disease.
Onu called on the public to avoid blaming the drug users, instead, they should help them to get treatment.
“Treatment of drug addiction reduces the prevalence of drug-related crimes and as well reduces the transmission of HIV/AIDs,” he said.
The consultant added that drug addiction was one of the emerging epidemics in the society.
A Director at Enugu State Hospital Management Board, Mr. Sam Egwuonwu, however, noted that it was necessary to sensitise the public, especially at the community level about the danger associated with drug addiction.
Egwuonwu added that this would help in reducing illicit drug use among the youths.
A participant, Mrs. Amaka Ekoh said that the forum had made her realize why most drug
addicts should not be tagged criminals.
Mr. Helen Ojukwu, another participant said it was necessary to sensitise students on the danger of drug addiction.